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Introduction
[R]efinement is never enough, and we should always seek further for
reduction and if possible replacement.
russell and burch, 1959, Chapter 4

Russell and Burch introduced the principles of replacement, reduction, and
refinement of animal experimentation in 1959 in their groundbreaking book,
The Principles of Humane Experimental Technique, to eradicate inhumanity towards non-human animals (hereinafter referred to as animals). They utilized
the term inhumanity to indicate negative mental states experienced by animals
used in research and the procedures that cause such mental states. Their goal
was to avoid the use of animals wherever possible and to improve significantly
the treatment of the animals still deemed indispensable, while improving the
quality of scientific and medical research and testing (Russell and Burch, 1959).
Since the 1990s, the 3Rs have slowly gained more acceptance within the animal
research community. They have been recognized by organizations such as the
Council of Europe (1986) and the World Organisation for Animal Health (2018),
and they have been implemented in law in several countries, for example in
Germany and in the UK (Herrmann, Köpernik and Biedermann, 2009; Zurlo,
Rudacille and Goldberg, 1996).
Today, the principles are not only embedded in legislation in the E
 uropean
Union (EU) but around the world (Bayne et al., 2015). In the EU, Directive
2010/63/EU on the protection of animals used for scientific purposes came
into effect in 2013, thereby requiring all EU Member States to implement the
© kathrin herrmann, ���9 | doi:10.1163/9789004391192_002
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3Rs fully. The EU Directive is more far-reaching compared to other legislation
since it promotes a strong shift away from animal experimentation, with its
goal being “full replacement of procedures on live animals for scientific and
educational purposes as soon as it is scientifically possible” (European Parliament, 2010, Recital 10). Furthermore, the EU Directive mandates that replacement should be the first priority, followed by reduction and then refinement
to be implemented if animal use is deemed absolutely unavoidable (European
Parliament, 2010, Recital 11). Russell and Burch (1959, Chapter 7) proposed the
following hierarchy: “Suppose, for a particular purpose, we cannot use replacing techniques. Suppose it is agreed that we shall be using every device of
theory and practice to reduce to a minimum the number of animals we have
to employ. It is at this point that refinement starts, and its object is simply to
reduce to an absolute minimum the amount of distress imposed on those animals that are still used.”
As a result of the incorporation of the 3Rs into legislation, which has mainly
been driven by ever-increasing societal concerns (cf. Clemence and Leaman,
2016; European Citizens’ Initiative, 2016; Jones, 2017; Pew Research Center,
2015, 2018), it would seem reasonable to expect changes within the research
industry, particularly replacement of animals with non-animal models. However, the cumulative effect of any such replacements has not prevented the
overall number of animals used from steadily increasing since the 2000s (European Commission, 2013; Taylor et al., 2008; Taylor and Rego, 2016). When looking at the 3Rs and their impact, it seems that refinement, the R of ultima ratio,
is receiving the most attention by the laboratory animal science c ommunity
(AALAS, n.d.; FELASA., 2016), especially in basic and applied research where
the majority of animals are utilized (in the EU, 65% of animals; cf. Daneshian
et al., 2015). A survey conducted with participants of laboratory animal science
training courses in four European countries found that refinement was seen as
more feasible and more pressing than replacement and reduction of animal
use (Franco, Sandøe and Olsson, 2018).
Due to this focus, the chapter starts by exploring the application of several
refinement methods in practice, commencing with current housing and husbandry standards and a discussion about the benefits of a “culture of care”,
followed by assessing important experimental refinements. To further assess the quality of animal-based research, it reviews necessary refinements
in planning, conduct, and reporting practices of animal studies. The chapter then moves on to look at feasible ways to reduce and replace animal use
by, first discussing tools to appraise animal studies whose application could
lead to a significant reduction of animal experiments and thus numbers of
animals used. It subsequently reflects on what the scientific community has
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been doing to move towards replacement of animals in research, testing, and
education. Finally, the chapter concludes with recommendations for steps to
be taken to work towards using non-animal, human-relevant approaches to
biomedical research and testing aimed to protecting human health.
2

Refinement of Animal Housing and Husbandry
Husbandry is a factor for contingent inhumanity in all types of experiment.
russell and burch, 1959, Chapter 4

Animals used in research, testing, and education spend their lives in a captive environment that is very different from their natural environment. Refined housing
gives animals the opportunity to cope with some of the stressors imposed by life
in the laboratory (Mason, 2006). Improving their living conditions by trying to
meet some of the animals’ basic behavioral needs is called environmental refinement or environmental enrichment (EE). Krech, Rosenzweig and Bennett (1960)
were the first to report biochemical changes in the brains of rats kept in a complex housing environment and augmented with daily exposure to novel items in
an open field. They coined the term EE when describing this paradigm (Benefiel,
Dong and Greenough, 2005). Environmental Enrichment is defined as “[a]ny
modification in the environment of captive animals that seeks to enhance the
physical and psychological well-being of the animals by providing stimuli which
meet the animals’ species-specific needs” (Baumans and van Loo, 2013). It includes complex social and inanimate object stimulation (Rosenzweig, 1966). Its
positive behavioral effects were first described in rats by Hebb in 1947, who
kept them as companion animals in his home. He observed that the rats living
in a more complex, stimulating environment learned better and more quickly
(Hebb, 1947). In addition to enhancing cognition, EE also promotes neuronal
activation, signaling and plasticity in a number of brain regions (Nithianantharajah and Hannan, 2006). In the beginning, research on EE was conducted primarily to assess changes in behavior and brain development. With the increased
concern for animal welfare and the establishment of animal welfare science as a
specific discipline, has EE been applied to improve the animals’ daily lives.
Aside from being driven by animal welfare and health concern, many eerelated research projects have also assessed the influence of poor housing conditions on research data. Garner (2005), van Praag, Kempermann and Gage
(2000), and Würbel (2001, 2007), among others, demonstrated that life in barren cages leads to abnormal brain development and to physiological and behavioral malfunction. Standard non- to little-enriched cages can cause a variety
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of abnormal behaviors, such as stereotypies (abnormal repetitive behaviour
patterns) (see e.g., Würbel and Stauffacher, 1994, 1996; Würbel, Stauffacher and
Holst, 1996) and inactivity while awake, observed for example in rhesus monkeys (Hennessy et al., 2014) and mice. Inactivity appears to be an alternative to
stereotypic behavior and indicates a depression-like state (Fureix et al., 2016).
Nonetheless, for a period of time, a number of laboratory animal scientists
strongly believed that standardizing the animals’ environment—by housing
animals in barren cages—was essential to control environmental variables
(e.g., Bayne, 2005; Eskola et al., 1999; Gärtner, 1999; Tsai et al., 2002, 2003, 2006).
The assumption was that standardization was crucial to minimize both variation in the data and the risk of obtaining conflicting results in replicate studies. Many laboratory animal scientists were concerned that implementing EE
would add undesirable variation to their responses to experimental treatments
(e.g., Bayne, 2005; Eskola et al., 1999; Gärtner, 1999; Tsai et al., 2002, 2003, 2006).
However, eight mouse strains kept under such uniform, standardized conditions, and tested on highly standardized behavioral tests in different laboratories, showed significant laboratory dependent variations (Crabbe, Wahlsten
and Dudek, 1999). Since then, studies by Augustsson et al. (2003), van de Weerd
et al. (2002), Wolfer et al. (2004), and Würbel (2007) have demonstrated that
housing conditions can be enriched without increasing variability in experimental results. Additional experiments using mice confirmed earlier research
findings that basic environmental enrichments (shelters and nesting material) can be used without compromising the research data (André et al., 2018).
Furthermore, this study showed that data from mice who had access to shelters and nesting material is comparable to previous data collected under barren housing conditions, consistent with earlier findings (see Augustsson et al.,
2003). The authors concluded that the influence of enrichment on research
outcomes was trivial, and that nesting material and shelters could be used without negative impact on study outcomes or loss of comparability to previous
data obtained from animals living in impoverished cages. (André et al., 2018).
In the future, rather than using more animals in new experiments on this topic, a systematic review (SR) could be undertaken to provide an overview of the
accessible evidence and new knowledge without further animal use. It would
also point out knowledge gaps and assess the quality and validity of the conducted animal studies (for more on SRs of animal experimentation, see e.g., Systematic Review Center for Laboratory Animal Experimentation, syrcle, n.d. a).
This so-called standardization fallacy (Würbel, 2000), the belief that homogenization of study populations (using the same strain, age, sex, weight,
housing conditions, etc.) is an essential part of good experimental design, appears to be one driver for the irreproducibility of results and for the lack of
external validity (Bailoo, Reichlin and Würbel, 2014). External validity is the
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extent to which experimental results can be used as a basis for generalizations
to other human and non-human animal populations in other environmental
conditions (van der Worp et al., 2010). This is why authors, including Richter,
Garner and Würbel (2009), Richter et al. (2010), Würbel (2000), and Würbel and
Garner (2007), promote systematic environmental heterogenization, which is
a “controlled and systematic variation of the properties of any given animal (or
animal population) and its environment within a single experiment” (Richter, 2017, p. 344). Voelk et al. (2018) compared 440 single- and multi-laboratory
preclincial animal studies that had used the same overall number of animals.
They compared effect size estimates and found that the studies conducted in
one laboratory only, in most cases did not predict effect size correctly, whereas multi-laboratory studies generated more consistent and accurate results.
Within-study standardization was identified as a major cause of poor reproducibility. Thus, Voelk et al. (2018) advocate for multi-laboratory design with
no increase of overall number of animals being necessary to enhance reproducibility and, potentially, external validity.
EE combined with systematic heterogenization contributes to improved
quality of animal experiments (Richter, Garner and Würbel, 2009; Richter
et al., 2010; Würbel, 2000; Würbel and Garner, 2007), whereas failure to provide
animals with living conditions that meet their species-specific needs jeopardizes both their welfare and experimental validity (e.g., Bailey, 2018; Balcombe,
2010; Bayne and Würbel, 2014; Garner, 2005; Messmer et al., 2014; Olsson et al.,
2003; Poole, 1997; Sherwin, 2004; Würbel, 2001, 2007; Würbel and Garner, 2007).
2.1
Examples of Environmental Refinement
An example of an extensively researched refinement method is providing mice
with various types and sufficient amounts of nesting material to build nests,
creating a microclimate needed for breeding and for preventing cold stress
(Gaskill et al., 2009, 2012; Gaskill and Garner, 2014; Hess et al., 2008). The thermoneutral zone of mice lies between 26°C and 34°C (Gordon, 1993); and standard temperatures in animal vivariums range between 20°C and 24°C. During
their inactive phase, mice prefer temperatures of 30°C–32°C (Gordon, 2012).
A proper nest is, therefore, essential for reducing cold stress, which not only
compromises animal well-being but also scientific data (Gaskill et al., 2009;
Karp, 2012; Messmer et al., 2014). Gaskill et al. (2013) additionally demonstrate
its negative effect on breeding performance. Nest building is a species-specific
behavior of mice, the absence of which can be used as an indicator of illness
(Gaskill and Pritchett-Corning, 2016). Another example involves gerbils, who
have a high motivation to dig, since they naturally build and live in burrows.
In standard laboratory conditions, where there is not enough substrate to dig
tunnels, gerbils show stereotypic digging behavior (Wiedenmayer, 1997). One
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solution, based on research conducted by Waiblinger and König (2004), is a
nesting box with an attached tunnel. The artificial burrow system seems to
help reduce stereotypic digging behavior.
Jirkhof (2015) found that housing conditions that meet the needs of mice
help them recover better and faster from experimental procedures. The influence of environment on diseases, such as cancer, has also been demonstrated;
for example, by Cao et al. (2010). In colon cancer and melanoma research,
mice living in an enriched environment showed reduced tumor growth and
increased remission compared to those living in a non-enriched environment
(Cao et al., 2010). Rabbits who received special positive attention from their
care givers showed a markedly increased resistance to the development of
atherosclerosis compared to rabbits who received no extra attention (Nerem,
Levensque and Cornhill, 1980).
2.2
Discussion on Environmental Refinement
It has been established that animals in a monotonous environment frequently display abnormal behaviors, such as stereotypies (Garner, 2005; Garner and Mason, 2002; Gross et al., 2012; Howerton, Garner and Mench, 2008;
Würbel and Stauffacher, 1994, 1996; Würbel, Stauffacher and Holst, 1996).
Furthermore, research has demonstrated the importance of environmental refinement, not only for animal welfare and for decreasing the negative
health effects of life in captivity, but for its benefits for research outcomes
in terms of their reliability, replicability, and validity (e.g., Abou-Ismail and
Mahboub, 2011; Garner, 2005; Weed and Raber, 2005).
Due, at least in part, to enforcement of animal protection laws, housing
conditions for laboratory animals have improved over the past decade. In the
EU, the Commission Recommendation of 18 June 2007 on guidelines for the
accommodation and care of animals used for experimental and other scientific purposes (Commission of the European Communities, 2007)—which was
later largely adopted by Directive 2010/63/EU (European Parliament, 2010,
Annex iii)—helped to enhance the captive environment of laboratory animals. However, exceptions to these minimum requirements may be demanded
by researchers for certain experiments. Examples include housing social species, such as rats, pigs, or non-human primates, individually and away from
their social groups; or not providing rodents with sufficient nesting material
and shelters, to allow easier and quicker monitoring. Yet, in most cases, a solution that considers the animals’ well-being and does not further compromise
their welfare could probably be found.
Moreover, it should be noted that the term most frequently used when talking about an improved living environment, environmental enrichment, can
be misleading, since it suggests that the standard cage conditions should be
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considered normal or species-typical. However, captive conditions have little in
common with the natural habitat of every single species used in research. For
example, Lahvis (2017) points out that the floor area in a standard mouse cage
is 280,000-times smaller than the animal’s natural home range. For rhesus macaques, he calculated it is 7 million-fold smaller. Along with the difference in the
size of the animals’ habitats, the stimulation provided in laboratories is also different from what animals encounter in their natural environments. Burghardt
(1996) argues that it would be more accurate to use the term controlled deprivation, since all captive environments deprive animals of some natural stimuli.
He points out that these restrictions have various, and oftentimes unpredictable, consequences for the welfare of captive animals (Burghardt, 1996, 1999).
In fact, a study by Gross et al. (2012) showed that around 12% of mice who lived
in enriched cages which contained nesting material, a shelter and a climbing
structure, still revealed stereotypic behavior. Moreover, evidence indicates that
when stereotypies are not observed, a potential reason could be that they are
only displayed when nobody is watching, e.g., in the nocturnal phase (Wells,
2017); or, since highly stereotypic animals seem to cope better than their
identically-treated conspecifics, non-stereotypic animals present an even
more abnormal, depression-like state as an alternative to stereotypic behavior
(Mason, 2006). It has been shown that sustained, uncontrolled stress can, at
least in some mouse strains, foster learned helplessness (Cabib, 2006).
2.3
Challenges in the Implementation of Refined Housing
The enforcement of animal protection laws has contributed to somewhat
improved housing conditions for laboratory animals over the past decade.
However, despite the mounting evidence of welfare and scientific problems
associated with standardized housing, the implementation of animal husbandry knowledge in laboratories has in the author’s experience been a major
and elusive challenge.
It is increasingly recognized that experimental animals experience serious
and repeated stress and distress, caused by life in the laboratory. Besides being
a welfare concern, there are multiple factors that adversely affect the animal’s
biological systems and thus the data collected from these animals (Bailey,
2018). Examples for stressors and thus potential influences on data, besides
the confinement itself, include ultrasonic noises (Baldwin, Primeau and Johnson, 2006; Turner et al., 2005), bedding material and cage cleaning (Burn et al.,
2006), handling, blood collection, and orogastric gavage (Balcombe, Barnard
and Sandusky, 2004), and the experimenters (Chesler et al., 2002) and their sex
(Baldwin, Primeau and Johnson, 2006; Sorge et al., 2014).
Numerous studies have shown that animals living in captive environments
are generally abnormal and unhealthy, as such environments change their

10

Herrmann

behavior as well as immune, nervous, and endocrine functionality. Examples
include their altered response to infection (Gurfein et al., 2014), altered immune
response (Beura et al., 2016; Messmer et al., 2014), increased rates of obesity,
Type ii diabetes, high blood pressure, and premature death (Martin et al., 2010),
altered brain development (Bennett et al., 1964; Kempermann, Kuhn and Gage,
1997; Lewis et al., 2006; Rosenzweig and Bennett, 1969; Rosenzweig et al., 1962),
decreased strength and endurance (During et al., 2015), altered sleep, activity
patterns, and blood pressure (Martire et al., 2012), altered growth rates (Serrat,
King and Lovejoy, 2008), altered organ development, metabolic, growth, and
reproduction rates and behavior (Gordon, 2012), and enhanced tumor growth
(Cao et al., 2010; Li et al., 2015). As such, untreated control animals do not represent healthy individuals, since they are metabolically abnormal (Martin et al.,
2010). To date, there are only a few studies comparing wild versus confined animals, but they all show immense biological differences in physiology, such as
structure variation of the visual cortex among caged and free-roaming Norway
rats (Campi et al., 2011), lower levels of cholesterol in wild versus captive animals
(Schmidt et al., 2006), and immune system dissimilarities (Beura et al., 2016).
We must acknowledge that even if laboratory animal housing is enriched, it
cannot be enriched to an extent that it has no negative effect on the animal’s
welfare (e.g., Burghardt, 1996; Gross et al., 2012). Well-being can only be achieved
if the animal experiences positive welfare states, which require a responsive environment the animal can engage with. Studies show that animals prefer complex environments and are motivated to work for them (Anselme, Robinson
and Berridge, 2013; Sherwin et al., 2004). Current minimum legal requirements
for animal housing in the European Union, laid out in Directive 2010/63/EU,
are still insufficient in meeting all needs of all animals; although they are held
to be the most progressive in the world. As shown, problems of confinement
are manifold. Animals’ lives in captivity are monotonous and, therefore, lead
to boredom (Burn, 2017; Meagher and Mason, 2012), learned helplessness and
depression (Cabib, 2006; Špinka and Wemelsfelder, 2011), and abnormal behaviors. The effects pose serious welfare concerns and raise concerns about the
validity and translatability of data obtained from these unhealthy individuals.
2.4
Potential Improvements
In assuming an ethical responsibility to improve the lives of captive animals
(Gruen, 2014), the goal of husbandry refinement should be not only to reduce
stressors but to promote well-being. It is apparent that current housing conditions do not achieve that. One step towards improving animal housing is
to provide cages that allow for more natural behaviors. Makowska and Weary
(2016a) investigated the frequency of burrowing, climbing, and standing
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upright of rats held in pairs in standard (behaviorally restrictive) laboratory
cages in comparison with rats in cages allowing these behaviors (larger cages
with lower floors, filled with moist soil, holding five rats per cage) over a period
of 13 months. Although climbing bouts decreased with age, standing upright
and especially burrowing were still frequent behaviors in older rats. Stretching
is a corrective response to stiffness caused by immobility or positional stress
(Bertolucci, 2011). Makowska and Weary (2016a) found that standard-housed
rats performed 9 times more lateral stretches than rats housed in the seminaturalistic environment. The authors proposed that standard-housed rats
were stretching frequently in an attempt to alleviate stiffness from low mobility associated with standard housing. Improved welfare of the rats housed in
the semi-naturalistic cages was observed in an anticipatory behavior test that
assessed differences in reward sensitivity performed when the rats were 19 and
21 months old (Makowska and Weary, 2016b).
From the animals’ perspective, an even better approach would be the radical solution for housing refinement proposed by Lahvis (2017). Lahvis suggests
that research animals should live in the wild or at least roam freely in a large,
captive environment under naturalistic conditions. He is confident that with
available technologies (e.g., cameras, transponders, magnetometers, pressure
sensors, global positioning systems), this novel approach could be accomplished for many experiments. Lahvis (2017) advises that biomedical researchers should work together with behavioral ecologists to develop sufficiently
complex environments in order to ensure that test subjects produce scientific
data not influenced by husbandry.
3

A “Culture of Care” for Animals as Refinement

The term culture of care has frequently been referred to by members of the
laboratory animal science community to demonstrate “a commitment to
improving animal welfare, scientific quality, care of the staff and transparency for the stakeholders.” (Norecopa, 2016a). For instance, a working document on the development of a common education and training framework
to fulfill Directive 2010/63/EU requirements mentions the culture of care
numerous times (National Competent Authorities for the implementation
of Directive 2010/63/EU on the protection of animals used for scientific purposes, 2014). Individuals responsible for the welfare of animals should establish and maintain high standards to champion a culture of care among both
husbandry and scientific staff (European Commission, 2014). Entire sessions
at conferences have been dedicated to this topic, including sessions at the
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European Society for Alternatives to Animal Testing (eusaat) Congress in
2015 (eusaat, 2015) and at the 10th European World Congress on Alternatives
and Animal Use in the Life Sciences in Seattle in 2017 (von Aulock, 2017).
Reinhardt (2003, p. 123) identifies compassion for laboratory animals as a
refinement: “Kindness and concern for animals in the laboratory often have
been stigmatized as subjective, emotional qualities that can undermine the
‘objectivity’ of biomedical and psychological research.” However, since there
is evidence that the human-animal bond helps animals to cope with stressful
situations in the laboratory (Wolfle, 1987), compassion for laboratory animals
should not be dismissed as emotional and subjective but as a sound methodological base for scientifically valid animal-based research (see Mahoney,
1992; Reinhardt, 2003). Compassion implies an acute awareness of an animal’s
state of emotional, behavioral, and physical well-being and the urge to provide
them with the conditions essential for optimal well-being (Reinhardt, 2003).
According to Herzog, “there is every reason to believe that individuals who
care about their wards on a personal level actually treat the animals better.”
(2002, p. 30). Morton highlights that, ideally, the staff assessing pain in animals should have an empathetic attitude toward them (Morton, 2000). Such
a mindset can also be seen as a protection mechanism to control unrelated,
potentially data-influencing, variables (Reinhardt, 2003). Brown (2014) states,
“Although there are laws and regulations that govern working with research
animals, institutions involved in research, testing, and teaching using laboratory animals should strive to go beyond what is legally required and work to
establish a ‘culture of care’ to ensure animals are treated with compassion and
respect.” Brown highlights that this culture of care for animals not only benefits animals but the quality of science as well.
3.1
From Theory to Practice
How far a culture of care is being implemented on an institutional level is
unknown. Personal experiences of this author—as an inspector of animal
research institutions in Germany between 2007 and 2016 (Herrmann, 2013;
Herrmann and Ratsch, 2010; Maurin, 2012)—revealed differences regarding
the level of care for animals within the same institutions, with individual care
givers acting more or less compassionately towards their animals. An institutional culture of care agenda could not be identified.
The European Commission (EC) (2014) recommends the implementation of such a culture, and other countries have taken steps, in this direction.
For example, New Zealand’s National Animal Ethics Advisory Committee
guide is called A Culture of Care: A Guide for People Working with Animals
in Research, Testing, and Teaching (National Animal Ethics Advisory Committee, 2002). Several p
harmaceutical companies, such as Sanofi-Aventis
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and Merck (Klein and Bayne, 2007), and commercial breeding companies
(Brown, 2014) are reported to have established culture of care programs; however, no external review or assessment of these programs has been published.
3.2
Towards a Culture of Care and Compassion for Animals
There is potential for a positive impact of a culture of care on animal use and
welfare. But how can we implement such a culture? Schuppli et al. (2017) used
a new educational approach to test if exposure to socialized rats, who were
trained to fulfill several tasks, fostered compassion among animal experimenters. Six rats were trained using positive reinforcement techniques to, for example, jump onto a scale, or to lift objects. Participants observed these rats
and engaged with handling them. After the class, researchers (17) discussed
their feelings and reactions. Main findings included that all participants were
impressed by the rats’ abilities and the close relationship with their trainers.
They assumed that this positive animal-human interaction decreased stress in
the rats. However, various views existed in regard to potential effects on data.
The experimenters expressed unease about emotional difficulties in “sacrificing” their experimental animals after having bonded with them (Schuppli
et al., 2017). This highlights one of the major obstacles: When animal
researchers develop compassion for their research subjects, they face moral
difficulties (see Birke, Arluke and Michael, 2007; Gluck, 2016) and moral harms
(see Chapter 13 in this Volume, Johnson and Smajdor, 2019) just as animal caretakers and technicians do. However, this could be an important starting point
in moving towards a culture of compassion for all animals which could contribute to their replacement efforts.
4

Refinement of Experimental Procedures

There are several essential refinement methods to reduce the pain, distress,
anxiety, and suffering inflicted during the course of experimenting on the animals. Handling and restraint techniques are a source of potential distress and
anxiety (Balcombe, Barnard and Sandusky, 2004; Hurst and West, 2010;
Meijer et al., 2006); and these techniques have been investigated in experimental studies on stress (Johnson, Sharp and Miller, 2000). To avoid negative effects on behavior, tail handling of mice should be replaced by using tunnels
or cupping mice in the open hand (Gouveia and Hurst, 2013). These and other
non-aversive handling practices should be implemented industry-wide, since
they have been shown to reduce anxiety (Hurst and West, 2010) and optimize
the performance of mice in behavioral tests (Gouveia and Hurst, 2017). A recent
study by Clarkson et al. (2018) concluded that particular handling methods can
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not only cause anxiety, but they can also alter the hedonic value of reward.
Tail-handled mice demonstrated a decreased responsiveness to reward and,
potentially, a more depressive-like state compared to tunnel handled conspecifics (Clarkson et al., 2018).
For surgical procedures, basic experimental refinements include: proper
acclimatization of the animals to the room where anesthesia will be induced
(Flecknell, 2018a); optimal anesthesia, peri- and postoperative analgesia; and
adequate postoperative monitoring and care, including pain management
(Flecknell, 2016; Herrmann and Flecknell, 2018a). The application of humane
endpoints also prevents needless suffering. A humane endpoint (or “lessinhumane endpoint,” see Balls, 1999, p. 1) represents “[t]he earliest i ndicator in
an animal experiment of (potential) pain and/or distress that, within its scien‑
tific context and moral acceptability, can be used to avoid or limit adverse
effects by taking actions, such as humane killing, terminating the study, or alleviating the pain and distress.” (Hendriksen, Morton and Cussler, 2011, p. 344).
The way an animal is killed is another subject for refinement. Animal care
policies in many countries stipulate that death must be painless, and fear and
anxiety should be minimized (e.g., Charbonneau et al., 2010; European Parliament, 2010). Less inhumane killing comprises the use of the least distressing
and least painful methods that cause rapid loss of consciousness and subsequent death (see e.g., Leary et al., 2013).
The application of our steadily increasing knowledge on experimental refinements should benefit the over 115 million animals who are used annually in
research, testing, and education around the world (Knight, 2008; Taylor et al.,
2008). However, this benefit cannot be achieved unless the knowledge is translated into practice. In cases where research workers plan to use, for example,
less than optimal anesthesia or analgesia protocols, or do not provide other
standard veterinary practices, they need to scientifically justify this and demonstrate that the anticipated benefits of the experiments still outweigh the
harms inflicted upon the animals (Herrmann and Flecknell, 2018b). Due to the
multitude of available means, solutions can be found, in most cases, that help
prevent needless animal suffering (Herrmann and Flecknell, 2018a).
4.1
The Use of Experimental Refinements in Practice
Several structured and systematic literature reviews have given some insight
on certain experimental refinements, notably, killing methods (Pound and
Nicol, 2018; Uhlig et al., 2015) and the use of anesthetics and analgesics (Bertrand, Sandersen and Flecknell, 2018; Carbone and Austin, 2016; Coulter, Flecknell and Richardson 2009; Coulter et al., 2011; Pound and Nicol, 2018; Richardson,
and Flecknell, 2005; Stokes, Flecknell and Richardson, 2009; Uhlig et al., 2015).
For example, animal research involving surgical procedures carried out on
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diverse species and published in peer-reviewed journals has been analyzed
with regard to analgesic and anesthetic administration (Coulter et al., 2011;
Coulter, Flecknell and Richardson, 2009; Richardson and Flecknell, 2005).
Stokes, Flecknell and Richardson (2009) focused on studies conducted in two
time periods (2000–2001 and 2005–2006), assessing trends in the administration of analgesics and anesthetics to laboratory mice and rats undergoing surgical procedures. The study showed a trend of improvement in terms of safer
anesthetic regimens used in the later period examined; however, the findings
of this study and an earlier review assessing analgesic use in rodents (Richardson and Flecknell, 2005) show that there was still significant scope for refinement, especially with respect to perioperative care.
A systematic review of anesthesia, analgesia and euthanasia methods used
in anesthesiology, respiratory and critical care research in top-10 impact factor ranked journals journals pointed to insufficient reporting of experimental
studies with small laboratory mammals. Despite the poor reporting, the review
found shortcomings in the application of refinement (Uhlig et al., 2015). Another recent attempt to assess trends in pain management, this time in papers
published before 2011 and from 2014 to 2015, further confirmed that reporting
(and probably the use) of experimental refinement methods is still poor (Carbone and Austin, 2016). The review demonstrated that scientific publications
still cannot be relied upon to present a detailed description of analgesia and
anesthesia protocols, not to mention other experimental refinements.
Another approach employed by the author of this chapter, with Flecknell
(2018 a, b, c), was to retrospectively review proposals for authorization of basic
and applied animal research studies to learn which experimental refinements
were proposed. Over 500 applications submitted to the German competent
authorities in 2010 were reviewed. German law stipulates that all possible refinements that are planned in an animal study are described in detail in its proposal. The review’s goal was to evaluate the intended application of and, thus,
the awareness about possible refinements. Among other results, postoperative
analgesia was not proposed for 30% of surgeries; and, in the majority of cases,
its scientific necessity was not further discussed. Following 10% of procedures,
animals were to be given pain relieving medication only if the investigators
decided that it was necessary; however, structured assessments to detect pain
were absent (Herrmann and Flecknell, 2018a).
4.2
Discussion on Refinement of Experimental Procedures
Structured and systematic literature reviews and the work of this author found
strong indications for flaws in the administration of experimental refinement.
Refinement methods need to be fully employed in order to minimize stressors
that can lead to distress, such as suffering from postoperative pain, or living
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in a barren cage. The biological consequences of stress and distress compromise rigor, reliability, and relevance of data collected from these animals (see
Bailey, 2018 for a review on how stress of laboratory life and experimentation
can adversely affect research data). Animal researchers are responsible for the
animals they use (National Health and Medical Research Council, 2013). Thus,
they and their animal care staff should know enough about animal behavior
to properly assess the health and well-being of their test subjects. In the European Union, they are legally required to be skilled, educated, and equipped
to detect and relieve suffering accordingly (European Parliament, 2010,
Article 24).
There are several challenging areas of refined care and use that should be
addressed. For example, there is a need for automated, remote, 24/7 cage-side
monitoring to identify abnormal behavior, which is especially important when
assessing the welfare of genetically modified animals, as well as for prey species who tend to mask their medical condition or psychological state. Additionally, there is a need for further development and implementation of valid
pain-assessment techniques to determine the efficacy of treatment in the individual animal due to individual variations in pain response. While there is
necessity for further research into certain areas of experimental refinement, it
is essential that we apply the knowledge we already have, so that immediate
improvements in animal welfare can be achieved.
5

Refinement of Experimental Design, Conduct, and Reporting

There have been quality problems throughout medical and biomedical research (Begley and Ellis, 2012; Harris, 2017; Pound and Bracken, 2014; Prinz,
Schlange and Asadullah, 2011). “The scandal of poor medical research” with human subjects was discussed in a British Medical Journal (bmj) editorial in 1994
(Altman, 1994). A biostatistician took a prominent stance against the unethical
misuse of statistics (Altman, 1980). In a follow up 20 years later, another bmj editorial called, “Medical research—still a scandal,” concluded that matters have
become worse (Smith, 2014). It is apparent that the quality of in vivo research
with animal and human subject demands urgent improvement. Weaknesses in
design, conduct, and analysis of biomedical and public health research studies
yield misleading results and, thus, waste resources (Ioannidis et al., 2014). Since
legally-required animal data forms the basis of decisions to move forward to
human clinical trials, flawed animal research is additionally problematic.
Aside from evidence that many animal experiments that are performed
never get published (Scherer et al., 2018), a large part of what gets published is
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incorrect (e.g., Harris, 2017; Ioannidis, 2005; Freedman, Cockburn and Simcoe,
2015). Ioannidis (2005) argues that it is highly probable that most published
findings are indeed false. He drew his conclusion after conducting simulation
studies and SRs. He calculated that, at best, only one in three publications took
basic precautions to minimize bias (Ioannidis, 2005). Freedman, Cockburn
and Simcoe (2015) estimated that more than 50% of all preclinical studies in
the United States are unreliable, and that the financial damage of these irreproducible preclinical studies is US$28 billion per year. Their analysis revealed
that about 20% of the studies had an untrustworthy experimental design, one
quarter used media that contained contaminated cells and antibodies, and
in 18% of studies the data analysis was poor. All of these issues have contributed to the so-called reproducibility crisis in animal research (e.g., Aarts et al.,
2015; Baker, 2016; Begley and Ioannidis, 2015; Bracken, 2009; Collins and Tabak,
2014; Freedman, Cockbury and Simcoe, 2015; Ioannidis, 2005; Perel et al., 2007;
Pound et al., 2004; Pound and Bracken, 2014; Reichlin, Vogt and Würbel, 2016;
Scannel and Bosley, 2016; Würbel, 2016). A review of the literature by Bailoo,
Reichlin and Würbel (2014) strongly suggests that experimental design and
conduct of laboratory animal research are in need of improvement. A study
by Vogt et al. (2016) revealed that animal researchers working in Switzerland
do not apply basic principles of study design to avoid bias and do not properly
report their study outcomes. They also found that neither the Swiss regulatory
authority nor the international journals and their peer reviewers had adequate
knowledge to recognize these flaws.
In an attempt to improve the quality of research reports, several checklists
and guidelines have been put in place, such as Consolidated Standards of Reporting Trials (consort) and Standards for Reporting of Diagnostic Accuracy
(stard) for human clinical trials, Preferred Reporting Items for Systematic
reviews and Meta-Analyses (prisma) for SRs and meta-analyses, and Gold
Standard Publication Checklist (gspc), Animal Research: Reporting of In Vivo
Experiments (arrive) guidelines for animal research (Glasziou et al., 2014;
Hooijmans, Leenaars and Ritskes-Hoitinga, 2010) and HARRP, the harmonized
animal research reporting principles, which are a recent attempt by ICLAS
(International Council for Laboratory Animal Science) in harmonizing animal
research reporting to further improvements in the scientific rigor of animal
experiments (Osborne et al., 2018). The arrive guidelines (Kilkenny et al.,
2010) are the most widely known for reporting of animal-based experiments.
These guidelines have recently been complemented by the Planning Research
and Experimental Procedures on Animals: Recommendations for Excellence
(prepare) guidelines, which help to ensure quality when preparing animal
studies (Smith et al., 2017).
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The arrive guidelines were adopted by more than 1000 scientific journals,
and more than 20 funding agencies were expected to endorse them in 2010
(Baker et al., 2014; Enserink, 2017). Two years later, Baker et al. (2014) assessed
the degree to which they had been endorsed by reviewing journals, such as
Nature and PloS, and found that there was little improvement. The knowledge about and the use of reporting guidelines, such as the arrive guidelines, is still not widespread, as a study by Reichlin, Vogt and Würbel (2016)
has shown. Reichlin et al. asked animal experimenters in Switzerland to complete a questionnaire regarding their use of measures against risk of bias. Only
16% responded. The arrive guidelines were known by less than half (43.7%).
Furthermore, Carbone and Austin (2016) found no increase in reporting of analgesic use in the articles published in journals that had agreed to endorse the
arrive guidelines. Results of a recent randomized controlled trial of close to
1,700 scientists, who submitted papers to the scientific journal PLoS One, suggest that scientists are either ignoring the guidelines or are still unaware of
their existence. Another finding was that, even when an ARRIVE checklist was
completed, the correlating papers were actually not more compliant, which
may indicate that researchers do not know what is expected of them and why
providing this information is crucial, emphasizing the importance of proper
training (Enserink, 2017; Hair et al., 2018).
5.1
Sources of Bias in Animal-based Research
There is a large number of potential sources of bias in animal research. Not surprisingly, most published animal studies have some risk of bias (Macleod et al.,
2015). Safeguards to avoid bias in study design, conduct, and analysis include
randomization of treatment groups to eliminate systematic differences between them, blinding of investigator to treatment and to handling of data, and
reporting on sample size estimation (Macleod, 2011). Analytical errors may account for close to a quarter of the irreproducible studies (Freedman, Cockburn
and Simcoe, 2015); thus, knowledge about statistical methods is essential. Other suggested items for reporting include: a clear description of the hypotheses
tested or primary and secondary objectives of the study, housing and husbandry, including welfare-related assessments and interventions, adverse events,
and interpretation of results, taking into account the hypotheses/study objectives (Kilkenny et al., 2010). Part of the reproducibility and translatability crisis
is considered to be due to poor experimental design and conduct of animal
experiments (Bailoo, Reichlin and Würbel, 2014; Ioannidis, 2005; Macleod, 2011;
van der Worp, 2010; Würbel, 2016), including the influences of inappropriate
animal housing (Lahvis, 2017) and handling (Gouveia and Hurst, 2017), insufficient pain relief (Carbone and Austin, 2016; Herrmann and Flecknell, 2018a),
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as well as the absence of other refinements, such as careful monitoring, early
humane endpoints, and less inhumane killing methods to reduce pain, suffering, and distress (Herrmann and Flecknell, 2018b and 2018c). The other, and
perhaps larger, part is due to insurmountable species differences (Pound and
Bracken, 2014; Pound and Ritskes-Hoitinga, 2018), which Russell and Burch already discussed 60 years ago (1959, Chapter 5).
Another source of bias is selective reporting when publishing results of
animal experiments (Briel et al., 2013; Ioannidis, 2012; Landis et al., 2012; Lees
et al., 2012; Macleod et al., 2004; Pound and Bracken, 2014; Sena et al., 2010;
Tsilidis et al., 2013; Würbel, 2016). One problem relates to negative findings—
studies for which the original hypotheses were not proven. Some of these are
not published at all, which has long been recognized as a source of publication
bias. The second problem relates to studies that are reported incompletely. For
example, only the parts that demonstrate that the treatment is effective are
reported, with whole experimental groups excluded from reporting. This is selective outcome and analysis reporting bias (Ioannidis, 2012). These partially or
unreported studies may be repeated by others and thus represent an unnecessary waste of animal lives. Incomplete reporting of published findings makes it
impossible to replicate studies (Begley and Ellis, 2012). Because negative findings are often not published (Scherer et al., 2018), the value of published findings is over-estimated, which, in part, could explain some of the difficulties
in translating promising preclinical results into effective therapies for human
disease (Bath et al., 2009; Mergenthaler and Meisel, 2012; Sena et al., 2010).
Yet another pitfall is researchers’ freedom of flexibility in data collection,
analysis, and reporting, which dramatically increases false-positive rates in the
literature and, therefore, contributes to misleading animal research data and
overestimation of its significance. Regardless of the nominal endorsement of a
maximum false-positive rate of 5% (p ≤.05), standards for disclosing details of
data collected and analyzed make false positive results very likely ( Simmons,
Nelson and Simonsohn, 2011). The authors describe this as p-hacking. Oftentimes, an experimenter is more likely to find evidence that an effect exists
falsely than to find evidence that it does not correctly. This occurs because of
the investigators’ degree of freedom with regard to the amount of data collected and analyzed, the exclusion of certain observations made, the comparison or combination of conditions, the variables considered, and so forth. It
is uncommon for researchers to make these decisions before undertaking experiments. Their exploratory behavior is explained as ambiguity in how best
to make these decisions and the desire to find statistically significant results.
Confirmatory bias is another potential pitfall, since people tend to interpret ambiguous information in such a way that it supports a justifiable
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conclusion that matches their own aspirations (e.g., Dawson, Gilovich and Regan, 2002). HARKing (i.e., Hypothesizing After the Results are Known) (Kerr,
1998) is another common and problematic practice in science. Statistical tests
to differentiate true effects from random noise are designed for confirmatory
research, not exploratory research. Thus, when researchers change their a priori hypotheses after obtaining their results, this leads to false conclusions.
An additional area that urgently needs refinement is transparency and data
sharing to avoid publication bias and needless repetition of studies. Openness is a cornerstone of science and could help in reducing the reproducibility
problem science is facing (Errington et al., 2014; Harris, 2017; McNutt, 2014). It is
essential to discover and correct errors. The Food and Drug Administration Modernization Act of 1997 (fdama) (Food and Drug Administration, 2018) requires
scientists to register their hypotheses and endpoints in advance, if they plan to
run a clinical trial on potential new pharmaceutical drugs (ClinicalTrials.gov).
This new law went into effect in 2000. It also requires pharmaceutical companies to publish their results, thus, avoiding publication bias. Despite the insufficient enforcement of the law, as many scientists still do not report the results
of their studies (Harris, 2017), the indispensability of such provisions is demonstrated by the findings of a study conducted by Kaplan and Irvin (2015). They
assessed whether the fdama had any effect on study outcomes. Before the law
was in place, 57% of drugs or supplements showed benefits; after the law was
in place, 8% of the studies published confirmed their preregistered hypotheses
(Kaplan and Irvin, 2015). Such a prospective registration process is currently exceptional for animal-based studies, but it is unquestionably required in order
to enhance transparency, reduce selective reporting bias, and prevent duplication. The Center for Open Science, a nonprofit where researchers can register
their hypotheses a priori (https://cos.io) and Preclinical Trials, a platform for
registration at the outset of all types of animal studies (www.preclinicaltrials.
eu), will hopefully improve the current situation. An additional measure to improve transparency, and potentially reproducibility, is data sharing, which is a
requirement for publication by some major journals but many researchers still
refuse to share. By sharing data, errors can be discovered (e.g., Salzberg et al.,
2001). This is especially important in animal research, since it helps reduce the
number of animals used and sheds light on the real value of animal derived data.
5.2
Necessary Steps
The improved quality of human clinical trials was achieved by strategies to
minimize bias, a priori power analysis and further biostatistics, clear definition of the primary and secondary endpoints, data monitoring and auditing,
internationalization and inclusion of multiple centers, external steering committees and safety monitoring, rigid publication standards, trial registries, and
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more (Dirnagl and Fisher, 2012). The lessons learned from the improvement
of human clinical trial quality should be adopted by preclinical (Dirnagl and
Fisher, 2012) and all other biomedical research fields (Hartung, 2013), where
relevant and with appropriate changes, since flawed research is unscientific
and unethical. The ethical issues with research involving animals become extra
critical as needless animal suffering must be avoided, and as preclinical animal
data generally forms the basis for decisions whether to proceed to human clinical trials. Thus, in order to adhere to the 3Rs, the following efforts are crucial:
– Education and ongoing training of researchers in experimental design, statistical methods, and model selection (Justice and Dhillon, 2016).
– Close assistance in study design by institutional animal welfare bodies and
by biostatisticians.
– As a possible solution for the problem of false positives making their way
into the literature, some researchers suggest the p-value threshold should
be reduced to 0.005 (Chawla, 2017). Others say researchers should select and
justify p-value thresholds for their experiments, before collecting any data.
These levels should be based on factors such as the potential impact of a
discovery. These thresholds could then be evaluated via registered reports, a
type of scientific article in which methods and proposed analyses are peerreviewed before any experiments are conducted (Chawla, 2017).
– Transparency must be improved as it is crucial to document all anticipated
or exploratory steps in the study. Prospective registration of all animal studies with their hypotheses and endpoints is essential to prevent selectivereporting biases (Ioannidis, 2012) and avoid study duplications (Preclinical
Trials, n.d.).
– Disclosure and openness are critical elements of science for self-correction,
and they can help avoid poor practices, such as HARKing.
– The use of preparation and reporting guidelines, such as the prepare guidelines (Smith et al., 2017) combined with the arrive guidelines (Kilkenny
et al., 2010), should be a mandatory, legally required part of funding applications, project license applications, as well as publications. Education on how
to fill out the checklists and present the required information in the publication, as well as a focus on enforcement of compliance to both by journals, is
critical (Eisen, Ganley and MacCallum, 2014; Enserink, 2017; Hair et al., 2018;
Herrmann and Flecknell, 2018a).
– Raw data, analyses, and protocols must be made available to allow other
researchers to verify results. This can easily be achieved by using data repositories (e.g., https://datadryad.org or https://figshare.com).
– Reporting of all study outcomes to avoid traditional reporting bias and
selective outcome and analysis reporting bias should be mandatory (Ioannidis, 2012).
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– Retrospective assessments of animal studies (see Ec Expert Working Group
for Project Evaluation and Retrospective Assessment, 2013, pp. 28–32)
should be performed comprehensively and by independent experts; and all
results should be published to enhance transparency, minimize publication
bias, identify animal models lacking external validity, and, thus, improve future research.
– Mandatory data sharing so that other scientists can build on the work and
discover errors faster (cf. the error in the Human Genome Project discovered by Salzberg et al., 2001). Data sharing should be compulsory, especially
when research is publicly funded.
It is equally important that funding and regulatory bodies, animal ethics committees, animal welfare bodies, journal editors, and peer reviewers have a detailed knowledge of these topics in order to recognize flawed research studies.
This requires effective and thorough education and training of funders, animal
ethics and welfare committees, and regulatory body members on how to assess
animal research proposals (Vogt et al., 2016). Furthermore, in order to review
these applications in-depth, enough time and manpower are a prerequisite.
6

Refinement: Are We Doing What We Can?

As presented in this chapter, knowledge about and implementation of refinement of husbandry, experimental procedures and design, conduct, and reporting appears to still be patchy. Since adoption of refinement strategies has been
inconsistent, it would seem that rather than use additional animals to carry
out more refinement research, we should focus on the comprehensive application of existing refinements in animal laboratories as well as on reducing and
replacing animals.
6.1
But What about the Refinement of Animal Models?
Animal models ought to describe a biological phenomenon that the model
species has in common with the target species. Significance and validity, in
terms of the translatability of results produced in an animal model to the human condition, “depend on the selection of a suitable animal model,” writes
Hau (2008, p. 4), which is why comprehensive knowledge about comparative
anatomy and physiology is essential. A majority of animal models developed
with the expectation to study the origin, disposition, and treatment of human disorders and is created through experimental induction, genetic modification, or breeding of disease-causing mutations (Hau, 2008, p. 4). These
presumed predictive models are used to find treatments or to assess the toxicity of drugs and other chemicals (Hau, 2008). Hence, they cause conditions
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associated with pain and distress up to severe, long-lasting suffering for these
animals.
Some laboratory animal scientists focus on the refinement of animal models in an attempt to reduce the suffering caused. Examples for refinement recommendations of animal models include those described for mice and rats
who are utilized as models of ischemic stroke (Percie du Sert et al., 2017), for
rheumatoid arthritis (Hawkins et al., 2015), in experimental autoimmune encephalomyelitis (eae) (Wolfensohn et al., 2013a), as models and in procedures
involving seizures, convulsions, and epilepsy (Lidster et al., 2016; Wolfensohn
et al., 2013b), and as models of sepsis and septic shock (Lilley et al., 2015). If
the gathering of such recommendations does not involve additional harmful
animal experiments, and in case these guidelines are then applied in practice,
they could lead to an improvement of the individual animal’s life.
However, due to failure of numerous models to predict human outcomes
(e.g., Joffe et al., 2016; Mak, Evaniew and Ghert, 2014; Pharmaceutical Research
and Manufacturers of America, 2015, 2016), and due to limited funding, it
seems crucial to first assess carefully which research methods and models to
use. In the case of sepsis models, for example, there have been multiple publications highlighting the differences in human and mouse immunology (e.g.,
Mestas and Hughes, 2004; Rittirsch, Hoesel and Ward, 2007; Seok et al., 2013;
Shay et al., 2013; Payne and Crooks, 2007). After over 20 years of unsuccessful
research in this field, a number of scientists finally investigated why, out of
the approximately 150 new compounds that were developed for the treatment
of sepsis using mice, not one had beneficial effects for humans. They identified around 5,000 genes that are activated or deactivated by inflammation in
humans who suffered from sepsis, trauma, or burns. They went on to look for
the same genes in one commonly-used strain of mice and realized that there
was no correlation (Seok et al., 2013). As a consequence of the dissimilarity
of mouse and human immune systems, the entire field of sepsis research in
mice has been called into question, regarding its predictive value for humans.
Paradoxically, funding for this kind of animal research, which is also known for
causing severe levels of animal suffering, is still ongoing (Leist and Hartung,
2013). At the same time, human-based sepsis research has led to clinical trials
of effective therapies (van der Poll, 2012).
7

Reduction and Replacement: Are We Doing What We Can?

Most animal research is being justified as indispensable to furthering human
healthcare. However, despite measures being taken to improve the quality of
animal-based research, the translational success rate from animal studies to
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humans is low: Less than 12% of drugs entering clinical trials result in an approved medicine (Pharmaceutical Research and Manufacturers of America,
2015, 2016); and between 51% and 89% of preclinical studies are not reproducible (Freedman, Cockburn and Simcoe, 2015; Harthorne and Schachner, 2012).
There is an ongoing debate among scientists as to why animal models fail to be
predictive: Is this mainly due to poor scientific rigor and reporting, to species
differences, or to the fact that today we mainly deal with complex, oftentimes,
chronic ailments of which many are not well understood and, thus, impossible
to model in other animals?
As a consequence of the failure to translate findings to humans, new criteria for mouse models have been described (Justice and Dhillon, 2016). Hoping to enhance animal models of stroke, Dirnagl and Fisher (2012) call for
international, multicenter, preclinical Phase iii-type studies of promising
new ischemic stroke therapies in animals before moving to clinical trial. As
Phase iii studies would be based on prior studies and would use various strains
and species (Dirnagl and Fisher, 2012), as well as older animals with various comorbidities (e.g., diabetes mellitus, obesity, and hypertension) (Mergenthaler
and Meisel, 2012), the severity of these experiments and the numbers of animals involved would markedly rise. Of close to 100 interventions that improved
the outcome in animal stroke models, which were tested in clinical trials, only
one intervention improved the outcome in human patients (O’Collins et al.,
2006). Despite decades of research, most translational stroke trials that aim
to extrapolate basic research findings into clinical treatments, particularly in
the area of neuroprotection, have failed (Mergenthaler and Meisel, 2012). The
authors admit that, to date, there is no ideal animal model for stroke, and that
more complex models are needed to improve translational success in experimental stroke research (Mergenthaler and Meisel, 2012). Thus, at the time of
writing, Mergenthaler and his colleague Stachelscheid are developing human
stem cell-derived 2D and 3D models for stroke (vfa, 2017). Building on the latest in vitro research to model human brain development and disease, they plan
to employ a recently established protocol for generating 3D brain tissue, socalled cerebral organoids, from human pluripotent stem cells that can be applied to study a number of human brain diseases (Lancaster and Knoblich,
2014). Renner et al. (2017) further examined the development and potential
differentiation of cerebral organoids, which hold great potential to advance
human-relevant stroke research.
7.1
Potential for Reduction by Critical Appraisal of Animal Studies
Several unsuccessful animal models have been discussed, such as for Alzheimer disease (Cavanaugh, Pippin and Barnard, 2014; Pippin, Cavanaugh and
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Pistollato, 2019, Chapter 20 in this Volume; Pistollato et al., 2016), for stroke
(Shuaib et al., 2007; van der Worp et al., 2010), for tuberculosis (Fonseca et al.,
2017); for asthma (Mullane and Williams, 2014), for hiv/aids, for neurological,
menopausal human therapy, and for cancer research as well as drug development (Pippin, 2012). Since only disease models with high predictive validity are
likely to yield positive results and treatments for humans, it is critical to assess
the reliability, reproducibility, and validity of the animal model first. With the
overall low quality and predictive validity of the majority of research studies,
it has become evident that animal-based studies require rigorous evaluation
(Pound et al., 2004). A solid methodological approach would be to systematically review and to perform meta-analyses of animal studies, as SRs are seen by
experts in the field of evidence-based medicine as the highest level of medical
evidence (Hooijmans, Leenaars and Ritskes-Hoitinga, 2010).
7.1.1
Systematic Reviews (SRs)
A systematic review (SR) is a literature review that focuses on a specific question with the aim to identify and assess all relevant studies in order to generate
new, high-quality evidence. Thus, it enables evidenced-based decision making
(Norecopa, 2017). A SR may contain a meta-analysis. In a meta-analysis, the
results of a number of independent studies are statistically combined to calculate the average effect of studies addressing the same question, which may lead
to more reliable conclusions and may help to minimize needless duplication
of animal studies (Hooijmans et al., 2014a). SRs conform with the implementation of the 3Rs concept (Ritskes-Hoitinga, 2016), as their application leads to a
more evidence-based choice of animal models (e.g., de Vries et al., 2012; Sloff
et al., 2014; Zeeff et al., 2016). They help decrease unnecessary animal studies,
the evidence they produce should further responsible animal use, and they
increase scientific quality (van Luijk, 2016), as they are an excellent tool to
assess study quality by evaluating the internal, external, and construct validity
of the models. Internal validity is the degree to which the design, conduct, and
analysis of the experiment remove potential bias, so that the interpretation of
a causal relationship between an experimental treatment and variation in an
outcome measure is secured (Bailoo, Reichlin and Würbel, 2014). The extent to
which animal data gives a basis for generalization to other animal and human
populations, including other environmental circumstances, represents the external validity; and construct or predictive validity shows how good the model
is, the rate to which the sampling properties are representative for the entities
they ought to represent (Bailoo, Reichlin and Würbel, 2014; Würbel, 2017). An
example for a SR on internal validity is the study of Macleod et al. (2008) and
for construct validity, the work of Sena et al. (2010), both focusing on reasons
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for translational failure of experimental stroke. SRs are a significant tool to
identify quality issues with primary animal studies. For example, a recent SR
on the welfare implications of toe clipping and ear notching revealed that the
underlying animal experiments were too flawed to draw conclusions (Wever
et al., 2017). SRs are excellent to assess the risk of bias in animal studies and
thus to evaluate the reliability of the available evidence (van Luijk et al., 2014).
Perel et al. (2007) systematically reviewed the success of treatments in animals
and in humans, with head injury, hemorrhage, thrombosis due to acute ischemic stroke, acute ischemic stroke, and osteoporosis as well as preventive
medication in neonatal respiratory distress syndrome, with their applications
in humans with these impairments. Their conclusion was that the incongruity
between animal and human studies may be due to bias or to the failure of the
animal models to mimic clinical disease (Perel et al., 2007).
SRs of animal studies are still much less common than in the clinical setting,
where they are frequently used to make evidence-based decisions on healthcare; but awareness of the benefits of the utility of SRs of animal research has
been increasing (Hooijmans et al., 2014; van Luijk et al., 2014). The Collaborative Approach to Meta-Analysis and Review of Animal Data from Experimental Studies (camarades) group, at the University of Edinburgh in the UK,
and the Systematic Review Center for Laboratory Animal Experimentation
(syrcle), at Radboud University Medical Center in the Netherlands, provide a
supporting framework for groups who are or want to get involved in the SR and
meta-analysis of data from experimental animal studies and offer advice and
training (camarades, 2014; syrcle, n.d. b). syrcle has published a step-bystep guide on how to identify all relevant animal studies (Norecopa, 2017), as
well as a tool similar to the Cochrane tool for assessing risk of bias in randomized clinical trials (Higgins et al., 2011), to assess the risk of bias in animal-based
studies (Hooijmans et al., 2014). It is important to receive proper training first,
as one needs to be aware of the pitfalls and limitations of these tools, and how
they can be misused and/or misleading (Gurevitch et al., 2018). Various types
of reporting biases, together with the limited methodological quality of some
studies on which meta-analyses and SRs are based, can impede their conduct
and interpretation (e.g., Benatar, 2007). When publication bias against negative animal studies exists, it will lead to an overestimate of the value of animal
studies. It is likely that if unpublished studies were to be included, then SRs
would show more studies with no effect in animals (Akhtar, Pippin and Sandusky, 2009). Checklists and tools have been proposed to help improve SRs and
meta-analyses (Hooijmans et al., 2014; Moher et al., 2009).
The use of SRs should be standard practice within animal-based research,
in the same way it has become a vital part of clinical research (Hooijmans,
Leenaars and Ritskes-Hoitinga, 2010; Hooijmans and Ritskes-Hoitinga, 2013;
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Pound and Bracken, 2014; Pound et al., 2004; Sandercock and Roberts, 2002).
SRs should be conducted prior to a new animal study to assess the validity of the proposed animal model and to avoid needless animal use (RitskesHoitinga and Wever, 2018). For example, in refinement research, SRs are an
efficient way to gather new high-quality data without having to experiment
on additional animals. As shown in this chapter, the implementation of new
knowledge about refinements to improve animal welfare has proven very
difficult. A prominent example is the use of carbon dioxide to kill animals.
Extensive research conducted on this welfare topic has produced overwhelming evidence against its use, but these findings still have not led to the abolishment of this common practice. At the time of writing, Turner et al. are
conducting a SR on the use of carbon dioxide as a killing method for mice and
rats. Their protocol (syrcle, n.d. c), as well as the protocols of others, are published on the syrcle website and, since 2018, protocols of SRs relevant to
human health can be registered at the international prospective register of
SRs, called prospero (https://www.crd.york.ac.uk/prospero/).
7.1.2
Other Retrospective Assessments
Conducting retrospective assessments (RAs) is a useful way to identify disease models and research methods that may be of limited value. Since 2013,
RAs are mandatory for certain animal studies in the European Union (European Parliament, 2010, Article 39). Members of the animal research inspectorates have been required to assess the outcomes of animal studies that were
classified as severe and/or use non-human primates. The animal researcher
has to submit the necessary documents so that the competent authority
can evaluate whether the study objectives were met, the actual harm inflicted, and whether the severity of procedures coincided with the prospective
assessments, and the number of animals used. In a ddition, the competent authorities must appraise any component that can advance the implementation
of the 3Rs (European Parliament, 2010, Article 39).
These RAs could be extremely effective in facilitating a critical review of the
use of animals in scientific procedures, if there are sufficient and qualified personnel to conduct them, as the EC’s aim with these RAs is to identify 3Rs improvements and enhance transparency to the public (EC Expert Working Group
for Project Evaluation and Retrospective Assessment, 2013). Publication of RA
results of all studies, including those that produced negative results and may
not be published elsewhere, would likely be of significant value. It would increase the knowledge base in a range of disciplines, reduce risks of duplication
of studies, and inform the design of future research (EC Expert Working Group
for Project Evaluation and Retrospective Assessment, 2013). However, only
about one sixth of all EU Member States agreed to make the RA results publicly
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available. This is not enough to meet the EC’s goals. To achieve maximum benefit, access to study results should be given not only to regulatory authorities but
to independent experts, in order for them to perform critical reviews of these
data. And all RA results have to be made publicly available. It is possible to do
so and still protect intellectual property by redacting and anonymizing certain
parts of the documentation.
7.1.3
Necessary Steps
As outlined earlier, the scientific and ethical justification for animal models
of human diseases depends on their providing an opportunity to investigate
disease biology and to determine potentially beneficial therapies for humans
(Benatar, 2007). Thus, only after an animal model has proven to have satisfactory predictive value for humans, should it be refined as much as possible to reduce pain, suffering, distress, and lasting harm. If proven of no value, it should
be abandoned. Such models should no longer receive regulatory approval nor
funding, nor should they be accepted by scientific journals. SRs and metaanalyses of animal models as well as RAs of all animal experiments performed by
independent experts would benefit animals and human patients, as they help
to identify flawed studies and to eliminate misleading, invalid models, and experimental designs. Such a rigid quality control of animal-based research would
most certainly lead to a significant reduction of animal use and, thus, to an increased effort to find more animal-free, robust, human biology-based models.
7.2

Is the Biomedical Research Industry Shifting away from Animal
Use?
The problem is that it hasn’t worked, and it’s time we stopped dancing
around the problem. […] We need to refocus and adapt new methodologies for use in humans to understand disease biology in humans.
zerhouni, former head of the US National Institutes of Health, quoted in
McManus, 2013

There is growing recognition that instead of focusing efforts on trying to refine animal experiments, a primary focus on human-relevant data is needed
(Collins, 2011; Giri and Bader, 2015; Langley et al., 2015, 2017; Zerhouni, 2014),
as a significant challenge that medical research is facing today is the understanding and possible treatment of chronic, complex diseases of which
many are not well understood and, thus, cannot be modeled in other animals
(Tsukamoto, 2016). Tsukamoto asks in a Drug Discovery Today editorial: “How
can we replicate human diseases that develop later in life and/or result from
a prolonged unhealthy lifestyle, far beyond the lifespan of rodent animals?
What makes us expect that the outcomes from carefully controlled animal

Refinement on the Way Towards Replacement

29

experiments can be duplicated in patients with substantial heterogeneity
across various aspects (age, gender, genetics, lifestyle, disease stage, etc.)?”
Transgenic mice commonly used as disease models, oftentimes contain multiple copies of presumed disease-causing transgenes, and it is dubious “whether phenotypes seen in mice as a result of this ‘genetic exaggeration’ have any
relevance to the corresponding human diseases” (Tsukamoto, 2016). Zerhouni
(2014) calls for a new approach that redirects the drug-development paradigm
that commences with the patient to explore the genetic foundation of molecular changes inherent to human pathophysiology.
As Russell and Burch remarked in 1959, “refinement is never enough, and
we should always seek further for reduction and if possible replacement”
(Chapter 4). Since 1959, we have gathered immense knowledge about animals
and their consciousness, which has led to the public acknowledgment by a
group of prominent neuroscientists that other animals are conscious too: The
Cambridge Declaration on Consciousness (Low, 2012). Since 1959, the technology revolution has also immensely changed the field of life sciences and,
hence, provides us with the tools to move away from using animals (Langley
et al., 2015, 2017).
Current legislation, reflecting societal concerns, as well as the scientific failures of animal research should function to drive research, testing, and education away from using live animals. Some areas of education and training are
already using animal-free teaching approaches, for ethical reasons and educational advances (see e.g., Bones et al., 2019, Chapter 23; Pawlowski et al., 2019,
Chapter 22 in this Volume). In the area of chemical-toxicity testing, some progress has already been made in finding advanced non-animal methods, initiated,
for example, through the pioneering Toxicology in the 21st Century (Tox21), a US
federal initiative (National Research Council, 2007; National Toxicity Program,
2004; Rovida et al., 2015; Zurlo, 2012). However, the general tendency in toxicology is to introduce new methods without eradicating all the old (animal-based)
ones (Rovida et al., 2015). Still, the acceptance of animal-free alternatives by
regulators without additional animal-based tests, in the pharmaceutical and
food-toxicity testing fields, should be possible when proven scientifically qualified for the specific context of use. However, awareness and acceptance of
scientically-valid, non-animal methods is still low among regulators as well as
research workers (Ramirez et al., 2015).
The high failure rate of drugs in the clinical phase (Begley and Ellis, 2012;
Food and Drug Administration, 2004; Hutchinson and Kirk, 2011; Kola and
Landis, 2004; Olson et al., 2000) indicates not only poor scientific quality and
cognitive bias but also that animals are not good models for humans (e.g.,
Greek and Kramer, 2019, Chapter 17 in this Volume; Kramer and Greek, 2018;
Knight, 2019, Chapter 14 in this Volume; Leist and Hartung, 2013); and the same
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applies to food-safety testing in animals (Rovida et al., 2015). Already back in
2000, an eye-opening report (Olson et al., 2000) was published about the results of a multinational pharmaceutical company survey, which served to better understand the concordance of the toxicity of pharmaceuticals in humans
compared with other animals. The weakness of animal studies to predict the
human toxicity of drugs became apparent, as results revealed a human toxicity
concordance rate of 71% when tested in multiple rodent as well as non-rodent
species. When they compared humans with rodent species only, there was a
43% correlation; humans compared with non-rodent species showed a 63%
match. Drug toxicity studies in animals are long-lasting and, hence, may cause
severe suffering; and they are frequently not predictive for effects in humans
(Hartung, 2009).
Cumulative knowledge is essential for scientific progress. Thus, there is
increasing awareness of the importance of data sharing and collaboration to
shift the paradigm away from using unsound animal models for drug toxicity
testing. The human toxome project, a systematic mapping of the entirety of
toxicity pathways, is ongoing in the area of chemical risk assessment. Rovida
et al. (2015) suggested that this project should be extended to include the assessment of efficacy and adverse effects of drugs and food ingredients. Continued reliance on animal models appears implausible to enhance the current poor rate of clinical approval of new treatments. This is why Humane
Society International initiated the Biomedical Research for the 21st Century
(BioMed21) Collaboration. The BioMed21 Collaboration is working internationally with health experts, regulatory and research agencies, funding
bodies, and others to develop innovative research roadmaps that focus on
understanding human disease pathophysiology.The goal is to further this humanfocused approach to studying, preventing, and treating disease (BioMed
21 Collaboration, n.d.). A central recommendation of the BioMed21 2015
workshop was to use the Adverse Outcome Pathway (aop) concept in biomedical research. aop, an important concept in toxicology, describes a logical
sequence of causally-linked biological events that lead from the first action of a
compound to an eventual adverse effect on human health (Langley et al., 2017).
Furthermore, it was recommended that technological advances should be combined in human-specific tools and models. The importance of funding these
new approaches was highlighted as well as the need for faster validation and
acceptance by the scientific community, funding bodies, and scientific journals, who mostly still postulate the use of animals (Langley et al., 2015, 2017).
BioMed21 is a rare example for a non-animal-based approach in the area of
applied research, which—together with the field of basic research—uses the
majority of animals. Overall, there is little evidence that these fields are reducing the use of animals, as the 3Rs posit we must. Quite the contrary: Animal use
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has been increasing in the new century (Taylor and Rego, 2016), mainly due to
an increasing generation and use of genetically altered animals (Bailey, 2019,
Chapter 19 in this Volume; Carbone, 2004; Ormandy, Schuppli and Weary, 2009;
Ram, 2019, Chapter 15 in this Volume), which has, in recent years, been fueled
by excitement over new technologies, such as crispr, an easier genetic modification technique that will most probably lead to a further steep increase in
animal numbers and species modified (Bailey, 2019). These new technologies,
however, have not kept their promise of improving translation between animal
models and human health, as they have failed to increase the efficiacy and the
safety of drugs (Hunter, 2011). For a detailed discussuion on the scientific and
ethical issues of the genetic modification of animals, see Chapter 19 in this
Volume (Bailey, 2019).
7.2.1
Funding
Progress in the development of replacement methods seems to be limited
most by the availability of funds. Some governments and non-governmental organizations around the world are providing scarce funding, especially when
compared to funds available for biomedical and life research as a whole. It is
unclear how much of the annual worldwide funds—an estimated US$100 billion for biomedical research alone (Chalmers and Glasziou, 2009) and up to
US$240 billion for all the life sciences (Røttingen et al., 2013)—are currently
used for research centered around the use of animals, as it is not differentiated
in the statistics (e.g., in Germany, bmbf, 2017). Daneshian (2016) estimated
that in 2015, funds for projects with animals in Germany, including animal research facilities, were about €1920 million; funds for replacement methods
ranged around €6.45 million. These financial means, mainly derived from German taxes, are distributed in opposition to Germany’s declared political goal of
working towards replacement of animal use at the national level (bmel, 2015)
as well as the EU level (European Parliament, 2010, Recital 10).
In preclinical human model development, the Tissue Chips for Disease Modeling and Efficacy Testing initiative, funded by US National Center for A
 dvancing
Translational Sciences (ncats) of the National Institutes for Health (nih), is
a rare example. Its goal is to explore human microphysiological systems as potential facilitators of drug development in numerous disease areas. Its budget is approximately US$15 million, annually, for 13 two-year projects (ncats,
2017); while nih, being the biggest funder and research organization in the
world, has annual funds of about US$39 billion for medical research alone
(nih, 2019). The EU framework program for research and innovation, Horizon 2020 (European Commission, n.d.), has, at the time of writing, supported
16 research projects devoted to alternative methods to animal testing, with a
total of €90 million (European Parliament, 2017). The main research activities
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are targeted towards developing complex in silico and in vitro human-based
systems for better and more cost-effective safety and efficacy testing of chemicals, nanoparticles, vaccines, and drugs (European Parliament, 2017).
Between 1981 and 2015, the German Federal Ministry for Education and Research (Bundesministerium für Bildung und Forschung, bmbf) gave €160 million in funding for over 500 3Rs research projects. Aside from not exclusively
funding replacement projects, the funds dedicated to the 3Rs were sparse; for
example, in the 6-year period between 2010 and 2015, less than €20 million
were available (bmbf, 2016). The UK National Centre of the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) is the largest funder
of such research in the United Kingdom (Burden et al., 2015). Between 2004 and
2014, NC3Rs awarded 200 grants worth approximately US$54 million (Burden
et al., 2015); the annual overall budget of NC3Rs is approximately €11.2 million
(NC3Rs, n.d. d). In contrast, the German national 3Rs center, Zentrum zum
Schutz der Versuchstiere (Bf3R), has an annual budget of €1.5 million to run all
of its operations (Bundesinstitut für Risikobewertung, 2016) and provides approximately €350,000 to external replacement and refinement research groups
per year (Bundesinstitut für Risikobewertung, 2018). Replacement research
has to compete with refinement research for these limited funds (bmbf, 2016;
NC3Rs, n.d. a).
A donor that exclusively provides money for the first R is the cosmetic company Lush, which in 2012 established the Lush Prize in collaboration with the
UK not-for-profit group, Ethical Consumer Research Association (Redmond,
2019, Chapter 27 in this Volume). Lush provides £250,000 in funding each year
for the main prize categories, with additional funds for regional awards in Asia
and the Americas (Lush Prize, n.d.). An example for a charity providing some
funding is People for the Ethical Treatment of Animals (peta) International Science Consortium (pisc), which, in June 2017, awarded funding to develop four
in vitro exposure systems to researchers from institutions in the United Kingdom, United States, and Belgium that are leaders in the development of nonanimal methods to test the toxicity of airborne substances (peta International
Science Consortium, n.d. a). pisc assists with funding where promising in vitro or in silico techniques require further development or validation in order
to gain regulatory acceptance. pisc focuses on toxicology and until, 2017, it
has contributed about €2.9 million towards improving and implementing
non-animal research methods (peta International Science Consortium, n.d.
b). The Alternatives Research & Development Foundation (ardf) funds and
promotes the development and validation of non-animal methods in biomedical research, product testing, and education and has provided US$3.25 million
in funds since 1993 (Alternatives Research & Development Foundation, 2018).
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The US National Anti-Vivisection Society (navs) provides some grants through
the International Foundation for Ethical Research (ifer) for early career scientists to develop humane, human-relevant alternatives that replace animal
use (navs, 2018). Overall, there are a few local and international initiatives and
prizes but most focus on animal testing, while non-animal approaches in basic
and applied research lag behind. Moreover, to ensure the field of animal-free,
human-based research methods and approaches is continually and substantially growing, increased, stable governmental funding must be provided.
7.2.2
Education and Training
Another obstacle in shifting the current research paradigm is the limited availability of educational and training courses on animal-free methods and approaches in all areas of biomedical science, but especially in basic and applied
research, since current available guidance documents and databases as well as
courses almost exclusively focus on testing alternatives. There are some efforts
being made to improve experimental design, conduct, and reporting; for example, online resources are available at some of the national 3Rs centers, such
as at Norecopa, Norway’s National Consensus Platform for the advancement of
the 3Rs (Norecopa, 2016b) and the UK NC3Rs (NC3Rs, n.d. b, c), since quality
issues of biomedical research has become apparent.
By EU law, the researcher must be well informed about state-of-the-art
developments in the field of investigation, and animals must only be used if
all possible alternatives are considered to be inadequate (EC Joint Research
Centre, 2013). The EC Joint Research Centre’s EU Reference Laboratory for
Alternatives to Animal Testing – European Centre for the Validation of Alternative Methods (eurl ecvam) Search Guide (EC Joint Research Centre, 2013)
and Data Base Service on Alternative Methods to animal experimentation
(DB-alm) (EC Joint Research Centre, 2017) ought to assist with the search for
alternatives to animal use. However, even for experts in the respective field,
it is a lengthy and difficult task, as existing search systems do not support the
necessary search strategies.
Altertox Academy, formerly caat Academy, offers hands-on training, but
primarily for toxicologists, in human-relevant alternative methods and technologies (Altertox Academy, 2018). Education and training courses, mandatory
for all animal researchers in the EU, include one animal-free methods module
(e.g., felasa B courses), but of a 40 hour felasa B course, about one hour is
dedicated to replacements, and generally only alternatives used in toxicology
testing are covered (e.g., Berliner Kompaktkurse, 2017, p. 23). In 2016, the University of California (UC) San Diego offered a course that introduces participants to the available non-animal research methods, their efficacy, and how to
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identify and implement them. It covered more areas than just regulatory toxicology (UC San Diego, 2018). However, detailed courses with extensive modules for all areas of the biomedical sciences currently do not exist.
7.2.3
Search Engine for Alternative Methods
What is urgently needed—aside from specific education and training
courses—is an unbiased, freely available search engine that is able to find
correlations regarding scientific purpose between animal experiments and
alternative methods and, at the same time, 3Rs-relevant deviances in the
methodologies (in vitro versus in vivo). Scientists from the Leibniz Institute
for Social Sciences (gesis) and the German Federal Institute for Risk Assessment (Bundesinstitut für Risikobewertung, BfR) have laid the foundation for
such a search engine, using machine learning. The project is called smafira,
which stands for “smart feature-based interactive ranking algorithm.” The goal
of smafira is to develop automated but mechanistically transparent search
procedures that focus on such deviations and, thus, to provide an improved
automatic support to search for non-animal methods (fisaonline, n.d.). This
search engine will drastically reduce the number of documents scientists have
to go through (gesis, n.d.). A first version of the smafira search engine is
anticipated to be available in the second half of 2019 (Daniel Butzke, BfR, personal communication, January 2019).
8

Ways to Work Towards Replacement

Directive 2010/63/EU, a progressive animal protection legislation in the field,
sums up some important steps that have to be taken to work towards a paradigm shift, when it states (emphasis added): “The availability of alternative
methods is highly dependent on the progress of the research into the development of alternatives. […] the Commission and the Member States should
contribute through research and by other means to the development and
validation of alternative approaches.” (Recital 46). Article 47 declares: “The
Commission and the Member States shall contribute to the development
and validation of alternative approaches which could provide the same or
higher levels of information as those obtained in procedures using animals
[…], and they shall take such other steps as they consider appropriate to encourage research in this field. […] Member States should, at national level,
ensure the promotion of alternative approaches and the dissemination of
information […]”.
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8.1
Political Engagement
The needed political engagement that Directive 2010/63/EU demands from its
Member States to move towards an animal-free world of scientific experimentation was made a priority by the Dutch government in 2016. The Netherlands
National Committee for the protection of animals used for scientific purposes
(NCad) has developed a vision and plan of action for moving away from laboratory animal use. The Dutch goal is to phase out the utilization of animals in
a number of fields by 2025, namely in regulatory testing of chemicals, food ingredients, pesticides and (veterinary) medicines, and biological products, such
as vaccines (NCad, n.d.). The Committee also plans to steadily reduce animal
involvement in regulatory preclinical research and basic research: “If we are to
make the transition to non-animal research methods, we must make a paradigm shift away from existing mindsets and practices” (NCad, n.d., p. 3), a task
which seems to be impossible without political involvement. The Dutch strategy holds the potential to act as a driver for other countries to follow this path.
8.2
Legislative Change
There is a need for regulators who are brave to move legislative change forward. The reason for the continued use of animals for regulatory testing is
legislative, as existing policies require that new drug candidates are tested on
animals before they can be assessed in human clinical trials, regardless of the
fact that these animal tests are often unreliable in assessing safety and efficacy
in humans (Greek and Kramer, 2019, Chapter 17 in this Voume). These regulations need to be amended according to scientific knowledge, and serious efforts need to be made to accelerate the development of advanced, humane,
and human-relevant models (Archibald, Coleman and Drake, 2019, Chapter 18
in this Volume).
8.3
Redeployment of Funds
Absolutely essential for the paradigm change towards advanced, animal-free
science and better healthcare is the redirection of funding. The limited funding for replacement research, oftentimes, has to compete with refinement
research (e.g., bmbf, 2016; NC3Rs, n.d. a). These scarce funds should be used
to further human biology-based approaches. Also, regarding taxpayers’ money,
the national governments, arguably, have the responsibility to use the funds in
the name of a society that has repeatedly voiced that more needs to be done
to replace animals in science. Moreover, our society is ethically evolving, with
evidence of dwindling acceptance for animal suffering in the name of science. And it is being increasingly acknowledged that the continued reliance
on animal models is unlikely to improve significantly the currently poor rate of
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clinical approval of new treatments. Thus, animal-based research also contributes to resources being wasted (Harris, 2017; Ioannidis et al., 2014; Keen, 2019,
Chapter 10 in this Volume).
Aside from redeploying funds, partially to preclinical human-relevant disease research (Langley et al., 2017) and to clinical rather than basic research
(Pound and Bracken, 2014), a large part of funding should be dedicated to disease prevention efforts. To combat the increasing prevalence of dementia, for
example, human-focused, non-animal models and methods, such as computational methods, advanced brain imaging techniques, and epidemiological
studies should be given funding preference (Pistollato et al., 2016). Another
extremely important area of disease prevention is basic public healthcare
(Marks, 2012) as well as nutrition and lifestyle education. In addition, funds
should also be used for pollution control, as pollution is currently found to be
the largest environmental cause of disease and premature death around the
world (Landrigan et al., 2017). The World Health Organization (who) estimated that around 3 million people die prematurely every year due to air pollution
alone (Watts et al., 2017). In 2015, diseases caused by pollution were responsible
for about 16% (9 Mio.) of all human deaths worldwide, which is three times
more than deaths from tuberculosis, malaria, and aids combined and 15 times
more than all wars and other means of violence together (Landrigan et al.,
2017).
8.4
Education and Training
Education as well as re- and ongoing training about how to conduct state-ofthe-art science and report it properly, as well as education on research ethics
and bioethics are crucial. They enable students and scientists to gain a solid
grounding in science based on non-animal models, while sincerely embracing the hierarchy of the 3Rs. Such learning objectives should be made available and should be mandatory for everyone planning to work or working in
biomedical science. Education and retraining are the most important means
to move away from the current thought culture and practice of animal use towards a new, humane research paradigm.
8.5
Scientific Collaboration
As Russell and Burch observed in 1959, “As we shall see, replacement is widely
used in some fields, while in others it is very far from being exploited to the
full, if at all. Moreover, such developments have been largely empirical, and
largely independent of each other” (Chapter 5). At the moment, 3Rs experts
are divided into replacement experts, on the one hand, and refinement experts, on the other. Animal welfare bodies and national committees in the
EU (Directive 2010/63/EU, Recital 48), for example, are supposed to advise
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scientists about the application of the 3Rs but seem to have little to no knowledge about available replacements and novel animal-free approaches to scientific questions (van Luijk et al., 2012; van Luijk et al., 2013). To achieve the
ultimate goal in shifting the focus from refinement of animal use to replacement of animal use the animal research community needs to engage with replacement experts. National 3Rs centers should be equipped with a majority of
experts in replacement methods, and a close collaboration between replacement experts and animal researchers appears crucial in moving towards animal replacement. To accelerate the development of new human biology-based
approaches, a multidisciplinary approach is essential for bringing together the
newest technologies and experts from various disciplines (Langely et al., 2017;
Noor, 2019, Chapter 25 in this Volume).
9

Final Remarks

Looking into the future of animal-based science, Carbone (2004) wrote that
morality and politics will continue to be the drivers for replacement research.
Since the introduction of the principles, it has been widely held that animal researchers have an ethical responsibility to minimize any pain, distress, fear, suffering, and harm caused to animals when keeping them confined and utilizing
them for invasive experiments without their consent. To apply the knowledge
gained through animal welfare and refinement research is good veterinary and
scientific practice, but it is not a substitute for reduction and replacement of
animal experimentation. Indeed, Balls warned “that refinement can be used
as a convenient way of showing commitment to the 3Rs, while ensuring that
animal experimentation is seen as respectable and can be allowed to continue,
while the fundamental ethical questions raised by it are avoided” (2010, p. 21).
Thus, we have to be on guard that refinement is not used as a whitewashing
tool, but its full application, which is an ethical imperative, must be guaranteed during the transition to human-relevant, animal-free methodologies.
Aside from extensive flaws in the way the majority of animals are housed
and treated, and the poor conduct and reporting of many animal studies, the
general lack of transparency around the use of animals in research as well as
the low rate of critical appraisal of animal experiments are apparent. These
failings have led to incorrect data and an overestimation of their significance
(Cohen, 2018). Unnecessary harm inflicted upon these animals and, in the case
of medical research, the harms done to patients who suffer from adverse reactions to drugs that were tested safe in animals or who are urgently waiting
for treatments are serious issues that need to be addressed. A commitment to
adhere to the 3Rs and to good scientific practice as well as to address societal
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concerns about the use of animals in science would require a strong shift away
from animals towards the use of human-relevant approaches.
References
Aarts, A.A., J.E. Anderson, C.J. Anderson, P.R. Attridge, A. Attwood and A. Fedor (2015).
Estimating the Reproducibility of Psychological Science. Science, 349(6251), pp. 1–8.
Abou-Ismail, U.A. and H.D. Mahboub (2011). The Effects of Enriching Laboratory
Cages Using Various Physical Structures on Multiple Measures of Welfare in SinglyHoused Rats. Laboratory Animals, 45(3), pp. 145–153.
Akhtar, A.Z., J.J. Pippin and C.B. Sandusky (2009). Animal Studies in Spinal Cord Injury:
A Systematic Review of Methylprednisolone. Alternatives to Laboratory Animals,
37(1), pp. 43–62.
AALAS (n.d.). AALAS National Meeting Abstract Archive. [online] Available at: https://
www.aalas.org/national-meeting/abstract-archive [Accessed 13 August 2018].
Altertox Academy (2018). Hands-on lab trainings and events in alternative methods in
toxicology. [online] Available at: http://academy.altertox.be [Accessed 12 August
2018].
Altman, D.G. (1994). The Scandal of Poor Medical Research. British Medical Journal,
308(6924), pp. 283–284.
Altman, D.G. (1980). Statistics and Ethics in Medical Research. Misuse of Statistics is
Unethical. British Medical Journal, 281(6249), pp. 1182–1184.
Alternatives Research & Development Foundation (2018). ARDF Annual Open Grant
Program. [online] Available at: http://www.ardf-online.org/ardf-grants.html [Accessed 12 August 2018].
André, V., C. Gau, A. Scheideler, J.A. Aguilar-Pimentel, O.V. Amarie, L. Becker, L. Garrett, W. Hans, S.M. Hölter, D. Janik and K. Moreth (2018). Laboratory Mouse Housing
Conditions Can Be Improved Using Common Environmental Enrichment Without
Compromising Data. PLoS Biology, 16(4), p. e2005019. [online] Available at: http://
journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.2005019 [Accessed 18
April 2018].
Anselme, P., M.J. Robinson and K.C. Berridge (2013). Reward Uncertainty Enhances
Incentive Salience Attribution as Sign-tracking. Behavioural Brain Research, 238,
pp. 53–61.
Archibald, K., R. Coleman and T. Drake (2019). Replacing animal tests to improve safety
for humans. In: K. Herrmann and K. Jayne, eds., Animal Experimentation: Working
Towards a Paradigm Change, Vol. 22. Leiden: Brill, pp. 417–442.
Augustsson, H., H.A. van de Weerd, C.L. Kruitwagen, V. Baumans (2003). Effect on
Enrichment on Variation and Results in Light/Dark Test. Laboratory Animals, 37(4),
pp. 328–340.

Refinement on the Way Towards Replacement

39

Bailey, J. (2018). Does the stress of laboratory life and experimentation on animals adversely affect research data? A critical review. Alternatives to Laboratory Animals,
46(5), pp. 291–305.
Bailey, J. (2019). Genetic modification of animals: scientific and ethical issues. In: K.
Herrmann and K. Jayne, eds., Animal Experimentation: Working Towards a Paradigm
Change, Vol. 22. Leiden: Brill pp. 443–479.
Bailoo, J.D., T.S. Reichlin and H. Würbel (2014). Refinement of Experimental Design
and Conduct in Laboratory Animal Research. ILAR Journal, 55(3), pp. 383–391.
Baker, M. (2016). 1,500 Scientists Lift the Lid on Reproducibility. Nature News, 533(7604),
p. 452.
Baker, D., K. Lidster, A. Sottomayor and S. Amor (2014). Two Years Later: Journals Are
Not Yet Enforcing the ARRIVE Guidelines on Reporting Standards for Preclinical
Animal Studies. PLoS Biology, 12(1), p. e1001756. [online] Available at: http://jour
nals.plos.org/plosbiology/%20article?id=10.1371/journal.pbio.1001756 [Accessed 12
August 2018].
Balcombe, J. (2010). Laboratory rodent welfare: thinking outside the cage. Journal of
Applied Animal Welfare Science, 13(1), pp. 77-88.
Balcombe, J.P., N.D. Barnard and C. Sandusky (2004). Laboratory Routines Cause Animal Stress. Journal of the American Association for Laboratory Animal Science, 43(6),
pp. 42–51.
Baldwin, A.L., R.L. Primeau and W.E. Johnson (2006). Effect of Noise on the Morphology of the Intestinal Mucosa in Laboratory Rats. Journal of the American Association
for Laboratory Animal Science, 45, pp. 74–82.
Balls, M. (1999). The biomedical sciences and the need for less inhumane animal procedures. In: C.F.M. Hendriksen and D.B. Morton, eds., Humane Endpoints in Animal
Experiments for Biomedical Research. London: Royal Society of Medicine Press,
pp. 1–4.
Balls, M. (2010). The Principles of Humane Experimental Technique: Timeless Insights
and Unheeded Warnings. Alternatives to Animal Experimentation, 27(2), pp. 144–148.
[online] Available at: http://www.altex.ch/resources/altex_2010_2_144_148_Balls
.pdf [Accessed 12 August 2018].
Bath, P.M.W., L.J. Gray, A.J.G. Bath, A. Buchan, T. Miyata and A.R. Green (2009). Effects
of NXY-059 in Experimental Stroke: An Individual Animal Meta-analysis. British
Journal of Pharmacology,157(7), pp. 1157–1171.
Baumans, V. and P. van Loo (2013). How to Improve Housing Conditions of Laboratory
Animals: The Possibilities of Environmental Refinement. The Veterinary Journal,
195(1), pp. 24–32.
Bayne, K. (2005). Potential for Unintended Consequences of Environmental Enrichment for Laboratory Animals and Research Results. ILAR Journal, 46(2), pp. 129–139.
Bayne, K. and H. Würbel (2014). The Impact of Environmental Enrichment on The
Outcome Variability and Scientific Validity of Laboratory Animal Studies. Revue

40

Herrmann

Scientifique et Technique de l’OIE, 33(1), pp. 273–280. [online] Available at: https://
www.oie.int/doc/ged/D13675.PDF [Accessed 12 August 2018].
Bayne, K., G.S. Ramachandra, E.A. Rivera and J. Wang (2015). The Evolution of Animal
Welfare and the 3Rs in Brazil, China, and India. Journal of the American Association
for Laboratory Animal Science, 54(2), pp. 181–191.
Begley, C.G. and L.M. Ellis (2012). Drug Development: Raise Standards for Preclinical
Cancer Research. Nature, 483(7391), pp. 531–533.
Begley, C.G. and J.P.A. Ioannidis (2015). Reproducibility in Science. Circulation Research,
116(1), pp. 116–126.
Benatar, M. (2007). Lost in Translation: Treatment Trials in the SOD1 Mouse and in
Human ALS. Neurobiology of Disease, 26(1), pp. 1–13.
Benefiel, A.C., W.K. Dong and W.T. Greenough (2005). Mandatory “Enriched” Housing of Laboratory Animals: The Need for Evidence-Based Evaluation. ILAR Journal,
46(2), pp. 95–105.
Bennett, E.L., M.C. Diamond, D. Krech and M.R. Rosenzweig (1964). Chemical and
Anatomical Plasticity of Brain. Science, 146(3644), pp. 610–619.
Berliner Kompaktkurse (2017). Laboratory Animal Science—Basic Course Main Focus:
Mice/Rats, p. 23. [online] Available at: https://www.berliner-kompaktkurse.de/
assets/files/downloads/ph_kk_2017-01_web.pdf [Accessed 1 July 2017].
Bertolucci, L.F. (2011). Pandiculation: nature’s way of maintaining the functional integrity of the myofascial system?. Journal of Bodywork and Movement Therapies, 15(3),
pp. 268–280.
Bertrand, H.G.M.J., C. Sandersen and P.A. Flecknell (2018). Reported analgesic and anaesthetic administration to non-human primates undergoing experimental surgical
procedure: 2010–2015. Journal of Medical Primatology, 47, pp. 217–225.
Beura, L., S. Hamilton, K. Bi, J. Schenkel, O. Odumade, K. Casey, E. Thompson, K. Fraser,
P. Rosato, A. Filali-Mouhim, R. Sekaly, M. Jenkins, V. Vezys, W. Haining, S. Jameson
and D. Masopust (2016). Normalizing the Environment Recapitulates Adult Human
Immune Traits in Laboratory Mice. Nature, 532(7600), pp. 512–516.
BioMed21 Collaboration (n.d.). About us. [online] Available at: http://biomed21.org/
about-us/ [Accessed on 23 May 2018].
BMBF (2016). Alternativen zum Tierversuch. Informationen zur Förderung. [online]
Availabale at: https://www.bmbf.de/pub/Alternativmethoden_zum_Tierversuch
.pdf [Accessed 1 August 2017].
Birke, L., Arluke, A. and Michael, M. (2007). The Sacrifice: How Scientific Experiments
Transform Animals and People. Purdue University Press.
BMEL (2015). “Mein langfristiges Ziel ist es, Tierversuche komplett zu ersetzen.”
Bundesminister Schmidt eröffnet das Deutsche Zentrum zum Schutz von Versuchstieren. [online] Berlin, 25. September 2015. Available at: https://www.bmel.de/DE/Tier/
Tierschutz/_texte/TierschutzTierforschung.html;jsessionid=DB4703F553CD731C7
EA41D8F642C806E.2_cid367?docId=6671414 [Accessed 12 August 2018].

Refinement on the Way Towards Replacement

41

Bones, V.C., R.C.M. Garcia, G.G. Alves, R.L. Paixão, A.A. Rocha, K.V. Capilé and R.
Bachinski (2019). Humane education: the tool for scientific revolution in Brazil. In:
K. Herrmann and K. Jayne, eds., Animal Experimentation: Working Towards a Paradigm Change, Vol. 22. Leiden: Brill.
Bracken, M.B. (2009). Why animal studies are often poor predictors of human reactions to exposure. Journal of the Royal Society of Medicine, 102(3), pp. 120–122.
Briel, M., K.F. Müller, J.J. Meerpohl, von E. Elm, B. Lang, E. Motschall, V. Gloy, F. Lamontagne, G. Schwarzer and D. Bassler (2013). Publication bias in animal research: A systematic review protocol. Systematic Reviews, 2, p. 23. [online] Available at: https://
systematicreviewsjournal.biomedcentral.com/track/pdf/10.1186/2046-4053-2-23
[Accessed 12 August 2018].
Brown, M.J. (2014). Creating a culture of care. NC3Rs News & Blog Online. [online]
Available at: https://www.nc3rs.org.uk/news/creating-culture-care [Accessed 12
August 2018].
Bundesinstitut für Risikobewertung (2016). Fragen und Antworten zum Deutschen
Zentrum zum Schutz von Versuchstieren (Bf3R). [online] Available at: http://www
.bfr.bund.de/cm/343/fragen-und-antworten-zum-deutschen-zentrum-zum-schutz
-von-versuchstieren-bf3r.pdf [Accessed 12 August 2018].
Bundesinstitut für Risikobewertung (2018). Bf3R Research Funding in the area of 3R
– Replacement, Reduction and Refinement. [online] Available at: https://www.bfr
.bund.de/en/bf3r_research_funding_in_the_area_of_3r___replacement__reduction
_and_refinement-62825.html [Accessed 12 August 2018].
Burden, N., K. Chapman, F. Sewell and V. Robinson (2015). Pioneering Better Science
through the 3Rs: An Introduction to the National Centre for the Replacement,
Refinement, and Reduction of Animals in Research (NC3Rs). Journal of the American Association for Laboratory Animal Science, 54(2), pp. 198–208.
Burghardt, G.M. (1996). Environmental enrichment or controlled deprivation? In: G.M.
Burghardt, J.T. Bielitzki, J.R. Boyce and D.O. Schaefer, eds., The Well-being of Animals in Zoo and Aquarium Sponsored Research. Greenbelt, MD: Scientists Center for
Animal Welfare, pp. 91–101.
Burghardt, G.M. (1999). Deprivation and Enrichment in Laboratory Animal Environments, Journal of Applied Animal Welfare Science, 2(4), pp. 263–266.
Burn, C.C. (2017). Bestial Boredom: A Biological Perspective on Animal Boredom and
Suggestions for Its Scientific Investigation. Animal Behaviour, 130, pp. 141–151.
Burn, C.C., A. Peters, M.J. Day and G.J. Mason (2006). Long-Term Effects of Cage-
Cleaning Frequency And Bedding Type on Laboratory Rat Health, Welfare,
and Handleability: A Cross-Laboratory Study. Laboratory Animals, 40(4),
pp. 353–370.
Cabib, S. (2006). The Neurobiology of stereotypy ii: The role of stress. In: G. Mason
and J. Rushen, eds., Stereotypic Animal Behaviour: Fundamentals and Applications to
Welfare, 2nd ed. Oxfordshire, UK: CAB International.

42

Herrmann

CAMARADES (2014). Bringing Evidence to Translational Medicine. [online] Available
at: http://www.dcn.ed.ac.uk/camarades/default.htm [Accessed 12 August 2018].
Campi, K.L., C.E. Collins, W.D. Todd, J. Kaas and L. Krubitzer (2011). Comparison of Area
17 Cellular Composition in Laboratory and Wild-Caught Rats Including Diurnal and
Nocturnal Species. Brain, Behavior and Evolution, 77, pp. 116–130.
Cao, L., X. Liu, E. Lin, C. Wang, E. Choi, V. Riban, B. Lin and M. During (2010). Environmental and Genetic Activation of a Brain-Adipocyte BDNF/Leptin Axis Causes
Cancer Remission and Inhibition. Cell, 142(1), pp. 52–64.
Carbone, L. (2004). What Animals Want: Expertise and Advocacy in Laboratory Animal Welfare Policy. New York: Oxford University Press.
Carbone, L. and J. Austin (2016). Pain and Laboratory Animals: Publication Practices
for Better Data Reproducibility and Better Animal Welfare. PLoS One, 11(5). [online]
Avaiable at: http://journals.plos.org/plosone/article/related?id=10.1371/journal
.pone.0155001 [Accessed 12 August].
Cavanaugh, S.E., Pippin, J.J. and Barnard, N.D. (2014). Animal Models of Alzheimer Disease: Historical Pitfalls and a Path Forward. Alternatives to Animal Experimentation, 31(3), pp. 279–302.
Center for Open Science (n.d.). Our Mission is to Increase Openness, Integrity, and
Reproducibility of Research. [online] Available at: https://cos.io/about/mission/
[Accessed 12 August 2018].
Chalmers, I. and P. Glasziou (2009). Avoidable Waste in the Production and Reporting
of Research Evidence. Obstetrics & Gynecology, 114(6), pp. 1341–1345.
Charbonneau, R., L. Niel, E. Olfert, M. von Keyserlingk and C. Griffin (2010). CCAC
Guidelines on: Euthanasia of Animals Used in Science. Canadian Council on Animal Care. Ottawa ON, Canada, pp. 1–32. [online] Available at: https://www.ccac.ca/
Documents/Standards/Guidelines/Euthanasia.pdf [Accessed 12 August 2018].
Chawla, S.D. (2017). ‘One-size-fits-all’ threshold for P values under fire. Scientists
hit back at a proposal to make it tougher to call findings statistically significant.
Nature News. [online] Available at: https://www.nature.com/news/one-size-fits-all
-threshold-for-p-values-under-fire-1.22625?WT.mc_id=TWT_NatureNews [Accessed
12 August 2018].
Chesler, E.J., S.G. Wilson, W.R. Lariviere, S.L. Rodriguez-Zas and J.S. Mogil (2002). Influences of Laboratory Environment on Behavior. Nature Neuroscience, 5, pp. 1101–1102.
Clarkson, J.M., D.M. Dwyer, P.A. Flecknell, M.C. Leach and C. Rowe (2018). Handling
method alters the hedonic value of reward in laboratory mice. Scientific Reports,
8(1), p. 2448. [online] Available at: https://www.nature.com/articles/s41598-018
-20716-3 [Accessed 12 August 2018].
Clemence, M. and J. Leaman (2016). Public Attitudes to Animal Research in 2016. A report by Ipsos MORI for the Department for Business, Energy & Industrial Strategy, Ipsos MORI Social Research Instititute. [online] Available at: https://www

Refinement on the Way Towards Replacement

43

.ipsos.com/sites/default/files/publication/1970-01/sri-public-attitudes-to-animal
-research-2016.pdf [Accessed 12 August 2018].
Cohen, D. (2018). Oxford TB Vaccine Study Calls into Question Selective Use of Animal
Data. British Medical Journal, 360, p. j5845.
Collins, F.S. (2011). Reengineering Translational Science: The Time Is Right. Science
Translational Medicine, 3(90), p. 90cm17. [online] Available at: https://www.ncbi
.nlm.nih.gov/pmc/articles/PMC5101940/ [Accessed 12 August 2018].
Collins, F.S. and L.A. Tabak (2014). NIH Plans To Enhance Reproducibility. Nature, 505,
pp. 612–613.
Commission of the European Communities (2007). Recommendation of 18 June 2007 on
Guidelines for the accommodation and Care of Animals Used for Experimental and
Other Scientific Purposes (2007/526/EC). Official Journal of the European Communities, L197, pp. 1–89. [online] Available at: https://eur-lex.europa.eu/legal-content/
EN/TXT/PDF/?uri=CELEX:32007H0526&from=EN [Accessed 15 August 2017].
Coulter, C., P. Flecknell and C. Richardson (2009). Reported Analgesic Administration
to Rabbits, Pigs, Sheep, Dogs and Non-Human Primates Undergoing Experimental
Surgical Procedures. Laboratory Animals, 43(3), pp. 232–238.
Coulter, C., P. Flecknell, M. Leach and C. Richardson (2011). Reported Analgesic Administration To Rabbits Undergoing Experimental Surgical Procedures. BMC Veterinary Research, 7(1), p. 12. [online] Available at: https://doi.org/10.1186/1746-6148-7-12
[Accessed 12 August 2018].
Council of Europe (1986). Convention for the Protection of Vertebrate Animals Used for
Experimental and other Scientific Purposes. European Treaty Series No. 123. [online]
Available at: https://rm.coe.int/168007a67b [Accessed 12 August 2018].
Crabbe, J.C., D. Wahlsten and B.C. Dudek (1999). Genetics of Mouse Behavior: Interactions with Laboratory Environment. Science, 284(5420), pp. 1670–1672.
Daneshian, M. (2016). Vergleiche der Förderungen von Alternativen in D
 eutschland –
Europa – USA. In: Forschung ohne Tierversuche – verliert Deutschland den Anschluss?
Zum Weltaktionstag gegen Tierversuche. Talk, Berlin. [online] Program available at:
https://www.urania.de/forschung-ohne-tierversuche-verliert-deutschland-den
-anschluss [Accessed 6 August 2017].
Daneshian, M., F. Busquet, T. Hartung and M. Leist (2015). Animal Use for Science in
Europe. Alternatives to Animal Experimentation, 32, pp. 261–274.
Dawson, E., T. Gilovich and D.T. Regan (2002). Motivated Reasoning and Performance
on the was on Selection Task. Personality and Social Psychology Bulletin, 28(10),
pp. 1379–1387.
de Vries, R.B., P. Buma, M. Leenaars, M. Ritskes-Hoitinga and B. Gordijn (2012). Reducing the Number of Laboratory Animals Used in Tissue Engineering Research by
Restricting the Variety of Animal Models. Articular Cartilage Tissue Engineering as
a Case Study. Tissue Engineering Part B: Reviews, 18(6), pp. 427–435.

44

Herrmann

Dirnagl, U. and M. Fisher (2012). International, Multicenter Randomized Preclinical
Trials in Translational Stroke Research: It’s Time To Act. Journal of Cerebral Blood
Flow & Metabolism, 32, pp. 933–935.
During, M.J., X. Liu, W. Huang, D. Magee, A. Slater, T. McMurphy, C. Wang and
L. Cao (2015). Adipose VEGF Links the White-To-Brown Fat Switch with Environmental, Genetic, and Pharmacological Stimuli in Male Mice. Endocrinology, 156,
pp. 2059–2073.
EC Expert Working Group for Project Evaluation and Retrospective Assessment (2013).
National Competent Authorities for the implementation of Directive 2010/63/EU
on the protection of animals used for scientific purposes. Working document on
Project Evaluation and Retrospective Assessment. [online] Available at: http://
ec.europa.eu/environment/chemicals/lab_animals/pdf/Endorsed_PE-RA.pdf
[Accessed 12 August 2017].
EC Joint Research Centre (2013). The EURL ECVAM Search Guide. Good Search Practice on Animal Alternatives. EUR 24391 EN, Re-edition. [online] Available at: https://
ec.europa.eu/jrc/en/publication/books/eurl-ecvam-search-guide-good-search
-practice-animal-alternatives [Accessed 12 August 2017].
EC Joint Research Centre (2017). EURL ECVAM Data Base Service on Alternative Methods to Animal Experimentation (DB-ALM). [online] Availble at: https://ecvam
-dbalm.jrc.ec.europa.eu/methods-and-protocols [Accessed 12 August 2018].
Eisen, J.A., E. Ganley and C.J. MacCallum (2014). Open Science and Reporting Animal
Studies: Who’s Accountable? PLoS Biology, 12(1), p. e1001757. [online] Available
at: http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1001757 [Accessed 12 August 2018].
Enserink, M. (2017). Sloppy reporting on animal studies proves hard to change. Science,
357(6358), pp. 1337–1338.
Errington, T.M., E. Iorns, W. Gunn, F.E. Tan, J. Lomax and B.A. Nosek (2014). An Open
Investigation of the Reproducibility of Cancer Biology Research. Elife, 3, p. e04333.
Eskola, S., M. Lauhikari, H.M. Voipio, M. Laitinen and T. Nevalainen (1999). Environmental Enrichment May Alter the Number of Rats Needed To Achieve Statistical
Significance. Scandinavian Journal of Laboratory Animal Science, 26, pp. 134–144.
European Citizen’s Initiative (2016). Stop Vivisection. [online] Available at: http://www
.stopvivisection.eu/de [Accessed 12 August 2018].
European Commission (2013). Report from the Commission to the Council and the
European Parliament. Seventh Report on the Statistics on the Number of Animals
used for Experimental and other Scientific Purposes in the Member States of the
European Union. COM (2013) 859 final. [online] Available at: https://eur-lex.eu
ropa.eu/resource.html?uri=cellar:e99d2a56-32fc-4f60-ad69-61ead7e377e8.0001.03/
DOC_1&format=PDF [Accessed 12 August 2018].
European Commission (2014). National Competent Authorities for the implementation
of Directive 2010/63/EU on the Protection of Animals Used for Scientific Purposes.

Refinement on the Way Towards Replacement

45

A working document on the development of a common education and training
framework to fulfil the requirements under the Directive. [online] A
 vailable at:
http://ec.europa.eu/environment/chemicals/lab_animals/pdf/Endorsed_E-T.pdf
[Accessed 15 July 2018].
European Commission (n.d.). Horizon2020. The EU Framework Programme for Research and Innovation. [online] Availble at: https://ec.europa.eu/programmes/
horizon2020/en/find-your-area [Accessed 12 August 2018].
European Parliament (2010). Directive 2010/63/EU of the European Parliament and of
the Council of 22 September 2010 on the Protection of Animals Used for Scientific
Purposes. Official Journal of the European Communities, L276, pp. 33–79. [online]
Available at: http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A320
10L0063 [Accessed 23 July 2017].
European Parliament (2017). Parliamentary questions: Question Reference E-004265/2017.
Answer given by Mr Moedas on behalf of the Commission. [online] Available at:
http://www.europarl.europa.eu/doceo/document/E-8-2017-004265-ASW_EN.html
[Accessed 12 August 2018].
EUSAAT (2015). 19th European Congress on Alternatives to Animal Testing, 16th Annual
Congress of EUSAAT. Alternatives to Animal Experimentation Proceedings, 4(2).
[online] Available at: http://www.eusaat-congress.eu/images/2015/Abstractbook
_EUSAAT_2015_Linz_2015.pdf [Accessed 12 August 2018].
FELASA (2016). Detailed program FELASA 2016. [online] Available at: http://felasa2016
.eu/wp-content/uploads/2016/06/DETAILED_PROGRAMME_FELASA_2016_
V3.6.pdf [Accessed 12 August 2018].
fisaonline (n.d.). SMAFIRA – Smart Feature-based interactive ranking (SMAFIRA) Project. [online]. Available at: https://fisaonline.de/en/find-institutions/federal-research
-institutions/?tx_fisaresearch_federalresearchinstitutions%5Bp_id%5D=4377&tx_
fisaresearch_federalresearchinstitutions%5Baction%5D=projectDetails&tx_fisaresearch_federalresearchinstitutions%5Bcontroller%5D=Projects&cHash=1223e8b0
7c976b94f16b67e2f0e4af1b#more [Accessed 23 Janaury 2018].
Flecknell, P.A. (2016). Laboratory Animal Anaesthesia. 4th ed., London: Academic
Press.
Flecknell, P.A. (2018). Rodent Analgesia: Assessment and Therapeutics. The Veterinary
Journal, 232, pp. 70–77.
Fonseca, K., P. Rodrigues, I. Olsson and M. Saraiva (2017). Experimental Study Of
Tuberculosis: From Animal Models To Complex Cell Systems and Organoids. PLoS
Pathogens, 13(8) [online] Available at: https://doi.org/10.1371/journal.ppat.1006421
[Accessed 12 August 2018].
Food and Drug Administration (2018). Food and Drug Administration Modernization
Act (FDAMA) [online] Available at: https://www.fda.gov/RegulatoryInformation/
LawsEnforcedbyFDA/SignificantAmendmentstotheFDCAct/FDAMA/default.htm
[Accessed 12 August 2018].

46

Herrmann

Food and Drug Administration (2004). Innovation or Stagnation? Challenge and Opportunity on the Critical Path to New Medical Products. US Department of Health and Human Services, Food and Drug Administration, pp. 1–32. [online] Available at: http://
www.who.int/intellectualproperty/documents/en/FDAproposals.pdf [Accessed 12
August 2018].
Franco, N.H., Sandøe, P. and Olsson, I.A.S. (2018). Researchers’ attitudes to the 3Rs—An
upturned hierarchy?. PloS One, 13(8), p. e0200895. [online] Available at: https://doi
.org/10.1371/journal.pone.0200895 [Accessed 17 August 2018].
Freedman, L.P., I.M. Cockburn, T.S. Simcoe (2015). The Economics of Reproducibility in
Preclinical Research. PLoS Biology, 13(6), p. e1002165. [online] Available at: https://
doi.org/10.1371/journal.pbio.1002165 [Accessed 15 July 2017].
Fureix, C., M. Walker, L. Harper, K. Reynolds, A. Saldivia-Woo and G. Mason (2016).
Stereotypic Behaviour in Standard Non-enriched Cages Is an Alternative To
Depression-like Responses in C57BL/6 Mice. Behavioural Brain Research, 305,
pp. 186–190.
Garner, J.P. (2005). Stereotypies and Other Abnormal Repetitive Behaviors: Potential
Impact on Validity, Reliability, and Replicability of Scientific Outcomes. ILAR Journal, 46(2), pp. 106–117.
Garner, J.P. and G.J. Mason (2002). Evidence for a Relationship Between Cage Stereotypies and Behavioural Disinhibition in Laboratory Rodents. Behavioural Brain
Research, 136(1), pp. 83–92.
Gärtner, K. (1999). Cage Enrichment Occasionally Increases Deviation of Quantitative
Traits. In: International Joint Meeting 12th ICLAS General Assembly and Conference
and 7th FELASA Symposium. Madrid: SECAL, pp. 207–210.
Gaskill, B. and J. Garner (2014). Letter-To-The-Editor on “Not so hot: Optimal Housing
Temperatures for Mice To Mimic the Thermal Environment of Humans”. Molecular
Metabolism, 3(4), pp. 335–336. [online] Available at: https://www.ncbi.nlm.nih.gov/
pmc/articles/PMC4060287/ [Accessed 12 August 2017].
Gaskill, B., C. Gordon, E. Pajor, J. Lucas, J. Davis and J. Garner (2012). Heat or Insulation: Behavioral Titration of Mouse Preference for Warmth or Access To a Nest.
PLoS One, 7(3), p.e32799. [online] Available at: http://journals.plos.org/plosone/
article?id=10.1371/journal.pone.0032799 [Accessed 12 August 2017].
Gaskill, B. and K. Pritchett-Corning (2016). Nest Building as an Indicator of Illness in
Laboratory Mice. Applied Animal Behaviour Science, 180, pp. 140–146.
Gaskill, B., S. Rohr, E. Pajor, J. Lucas and J. Garner (2009). Some Like It Hot: Mouse
Temperature Preferences in Laboratory Housing. Applied Animal Behaviour Science,
116(2–4), pp. 279–285.
Gaskill, B., C. Winnicker, J. Garner and K. Pritchett-Corning (2013). The Naked Truth:
Breeding Performance in Nude Mice with and without Nesting Material. Applied
Animal Behaviour Science, 143(2–4), pp. 110–116.

Refinement on the Way Towards Replacement

47

GESIS (n.d.). SMAFIRA Computer-aided modeling of signatures and features of relevant scientific content. Available at: https://www.gesis.org/en/research/externalfunding-projects/archive/smafira/ [Accessed 17 August 2017].
Giri, S. and A. Bader (2015). A Low-Cost, High-quality New Drug Discovery Process
Using Patient-derived Induced Pluripotent Stem Cells. Drug Discovery Today, 20(1),
pp. 37–49.
Glasziou, P., D.G. Altman, P. Bossuyt, I. Boutron, M. Clarke, S. Julious, S. Michie, D. Moher and E. Wager (2014). Reducing Waste from Incomplete or Unusable Reports of
Biomedical Research. The Lancet, 383(9913), pp. 267–276.
Gluck, J.P. (2016). Voracious Science & Vulnerable Animals. A Primate Scientist’s Ethical Journey. The University of Chicago Press: Chicago and London.
Gordon, C.J. (1993). Temperature regulation in laboratory rodents. New York: Cambridge
University Press.
Gordon, C.J. (2012). Thermal Physiology of Laboratory Mice: Defining Thermoneutrality. Journal of Thermal Biology, 37(8), pp. 654–685.
Gouveia, K. and J.L. Hurst (2013). Reducing Mouse Anxiety During Handling: Effect of
Experience with Handling Tunnels. PLoS One, 8(6), p. e66401.
Gouveia, K. and J.L. Hurst (2017). Optimising reliability of mouse performance in
behavioural testing: the major role of non-aversive handling. Scientific Reports, 7,
p. 44999, [online] Available at: https://www.nature.com/articles/srep44999 [Accessed 12 August 2018].
Greek, R. and L.A. Kramer (2019). The scientific problems with using non-human animals to predict human response to drugs and disease. In: K. Herrmann and K. Jayne,
eds., Animal Experimentation: Working Towards a Paradigm Change, Vol. 22. Leiden:
Brill.
Gross, A., S. Richter, A. Engel and H. Würbel (2012). Cage-induced Stereotypies, Perseveration, and the Effects of Environmental Enrichment in Laboratory Mice. Behavioural Brain Research, 234(1), pp. 61–68.
Gruen, L. (2014). The Ethics of Captivity. New York: Oxford University Press.
Gurevitch, J., J. Koricheva, S. Nakagawa and G. Stewart (2018). Meta-analysis and the
Science of Research Synthesis. Nature, 555(7695), pp. 175–182.
Gurfein, B.T., O. Davidenko, M. Premenko-Lanier, J.M. Milush, M. Acree, M.F. Dallman,
C. Touma, R. Palme, V.A. York, G. Fromentin, N. Darcel, D.F. Nixon and F.M. Hecht
(2014).Environmental Enrichment Alters Splenic Immune Cell Composition and
enhances Secondary Influenza Vaccine Responses in Mice. Molecular Medicine,
20(1), pp. 179–190.
Hair, K., Macleod, M. R., Sena, E. S. and IICARus Collaboration (2018). A randomised
controlled trial of an Intervention to Improve Compliance with the ARRIVE guidelines (IICARus). bioRxiv, p. 370874.
Hartshorne, J. and A. Schachner (2012). Tracking replicability as a method of post-
publication open evaluation. Frontiers in Computational Neuroscience, 6, p. 8.

48

Herrmann

[online] Available at: https://www.frontiersin.org/articles/10.3389/fncom.2012.
00008/full [Accessed 12 August 2018].
Hartung, T. (2009). Toxicology for the twenty-first century. Nature, 460(7252),
pp. 208–212.
Hartung, T. (2013). Food for Thought Look Back in Anger—What Clinical Studies Tell Us
About Preclinical Work. Alternatives to Animal Experimentation, 30(3), pp. 275–291.
[online] Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790571/
[Accessed 12 August 2018].
Harris, R. (2017). Rigor mortis. How sloppy science creates worthless cures, crushes hope,
and wastes billions. New York: Basic.
Hau, J. (2008). Animal models for human disease: An overview. In: P.M. Conn, ed.,
Sourcebook of Models for Biomedical Research. Totowa: Humana Press Inc., pp. 3–9.
Hawkins, P., R. Armstrong, T. Boden, P. Garside, K. Knight, E. Lilley, M. Seed, M. Wilkinson and R. Williams (2015). Applying Refinement to the Use of Mice and Rats in
Rheumatoid Arthritis Research. Inflammopharmacology, 23(4), pp. 131–150.
Hebb, D.O. (1947). The Effects of Early Experience on Problem Solving at Maturity.
American Psychologist, 2, pp. 306–307.
Hendriksen, C., D. Morton and K. Cussler (2011). Use of humane end points to minimise suffering. In: B. Howard, T. Nevalainen and G. Perretta, eds., The Cost Manual
of Laboratory Animal Care and Use. Florida: CRC Press, pp. 333–353.
Hennessy, M.B., McCowan, B., Jiang, J. and Capitanio, J.P. (2014). Depressive-like
behavioral response of adult male rhesus monkeys during routine animal

husbandry procedure. Frontiers in Behavioral Neuroscience, 8, p. 309. [online] Available at: https://www.frontiersin.org/articles/10.3389/fnbeh.2014.00309/full [Accessed 17 August 2018].
Herrmann, K. (2013). Directive 2010/63/EU—A Chance for More Humane Education?. In: 12th FELASA 2013 SECAL Congress “Animal Research: Better Science with
Fewer Animals”. Barcelona: SECAL, Abstracts of scientific papers 12th FELASA
SECAL Congress, Journal of the American Association for Laboratory Animal Science, 52(3), p. 389. [online] Available at: https://www.researchgate.net/publica
tion/282816209_jaalas_FELASA_2013 [Accessed 12 August 2018].
Herrmann, K. and P.A. Flecknell (2018a). Retrospective review of anesthetic and analgesic regimens used in animal research proposals. Alternatives to Animal Experimentation, 36(1), pp. 65–80. [online] Available at: https://www.altex.org/index.php/
altex/article/view/780/1234 [Accessed 14 September 2018].
Herrmann, K. and Flecknell, P.A. (2018b): Application of humane endpoints and
humane killing methods in animal research proposals – a retrospective review.
Alternatives to Laboratory Animals, 46(6), pp. 1–17.
Herrmann, K. and Flecknell, P.A. (2018c): Severity classification of surgical procedures
and application of health monitoring strategies in animal research proposals – a
retrospective review. Alternatives to Laboratory Animals, 46(5), pp. 273–289.

Refinement on the Way Towards Replacement

49

Herrmann, K., K. Köpernik and M. Biedermann (2009). Ein Leitfaden für die Teilprüfung der “Unerlässlichkeit” im Hinblick auf “Refinement”. In: D. Borchers and J. Luy,
eds., Der Ethisch Vertretbare Tierversuch, Kriterien und Grenzen, Padaborn: mentis,
pp. 219–234.
Herrmann, K. and H. Ratsch (2010): Bessere Haltungsbedingungen für Labortiere:
Überwachung von Versuchstierhaltungen – die Frage des Enrichments. Deutsches
Tierärzteblatt, 4, pp. 492–499.
Herzog, H. (2002). Ethical Aspects of Relationships Between Humans and Research
Animals. ILAR Journal, 43(1), pp. 27–32.
Hess, S.E., S. Rohr, B.D. Dufour, B.N. Gaskill, E.A. Pajor and J.P. Garner (2008). Home
Improvement: C57BL/6J Mice Given More Naturalistic Nesting Materials Build Better Nests. Journal of the American Association for Laboratory Animal Science, 47(6),
pp. 25–31.
Higgins, J.P., D.G. Altman, P.C. Gøtzsche, P. Jüni, D. Moher, A.D. Oxman, J. Savović,
K.F. Schulz, L. Weeks and J.A. Sterne (2011). The Cochrane Collaboration’s Tool for
Assessing Risk of Bias in Randomised Trials. British Medical Journal, 343, p. d5928.
Hooijmans, C.R., J. IntHout, M. Ritskes-Hoitinga and M.M. Rovers (2014a). Meta-
analyses of Animal Studies: An Introduction of a Valuable Instrument To Further
Improve Healthcare. ILAR journal, 55(3), pp. 418–426. [online] Available at: https://
www.ncbi.nlm.nih.gov/pmc/articles/PMC4276598/ [Accessed 15 July 2017].
Hooijmans, C.R., M. Leenaars and M. Ritskes-Hoitinga (2010). A Gold Standard Publication Checklist To Improve The Quality Of Animal Studies, To Fully Integrate The
Three Rs, And To Make Systematic Reviews More Feasible. Alternatives to Laboratory Animals, 38(2), pp. 167–182. [online] Available at: http://repository.ubn.ru.nl/
bitstream/handle/2066/89153/89153.pdf [Accessed 15 August 2017].
Hooijmans, C.R. and M. Ritskes-Hoitinga (2013). Progress in Using Systematic Reviews of Animal Studies To Improve Translational Research. PLoS Medicine, 10(7),
p. e1001482. [online] Available at: http://journals.plos.org/plosmedicine/article?id=
10.1371/journal.pmed.1001482 [Accessed on 14 November 2017].
Hooijmans, C.R., M.M. Rovers, R.B. de Vries, M. Leenaars, M. Ritskes-Hoitinga and
M.W. Langendam (2014b). SYRCLE’s Risk of Bias Tool for Animal Studies. BMC
Medical Research Methodology, 14(1), p. 43. [online] Available at: https://www.ncbi
.nlm.nih.gov/pmc/articles/PMC4230647/ [Accessed on 14 November 2017].
Howerton, C.L., J.P. Garner and J.A. Mench (2008). Effects of a Running Wheel-igloo
Enrichment on Aggression, Hierarchy Linearity, and Stereotypy in Group-housed
Male CD-1 (ICR) Mice. Applied Animal Behaviour Science, 115(1), pp. 90–103.
Hunter, A.J. (2011). Have Animal Models of Disease Helped or Hindered the Drug Discovery Process. Annals of the New York Academy of Sciences, 1245, pp. 1–2.
Hurst, J.L. and R.S. West (2010). Taming Anxiety in Laboratory Mice. Nature Methods, 7,
pp. 825–826. [online] Available at: https://www.nature.com/nmeth/journal/v7/n10/
full/nmeth.1500.html [Accessed on 14 January 2017].

50

Herrmann

Hutchinson, L. and R. Kirk (2011). High Drug Attrition Rates—Where Are We Going
Wrong?. Nature Reviews Clinical Oncology, 8(4), pp. 189–190.
Ioannidis, J.P.A. (2005). Why Most Published Research Findings Are False. PLoS Medicine, 2(8), p. e124. [online] Available at: https://doi.org/10.1371/journal.pmed.0020124
[Accessed 15 July 2017].
Ioannidis, J.P.A. (2012). Why Science Is Not Necessarily Self-Correcting. Perspectives on
Psychological Science, 7(6), pp. 645–654. [online] Available at: http://journals.sage
pub.com/doi/full/10.1177/1745691612464056 [Accessed 15 July 2017].
Ioannidis, J.P.A., S. Greenland, M.A. Hlatky, M.J. Khoury, M.R. Macleod, D. Moher,
K.F. Schulz and R. Tibshirani (2014). Increasing Value and Reducing Waste in
Research Design, Conduct, and Analysis. The Lancet, 383(9912), pp. 166–175.
Jirkof, P. (2015). Effects of Experimental Housing Conditions on Recovery of Laboratory
Mice. Lab Animal, 44(2), pp. 65–70.
Joffe, A.R., M. Bara, N. Anton and N. Nobis (2016). Expectations for the Methodology and Translation Of Animal Research: A Survey of the General Public, Medical
Students, and Animal Researchers in North America. Alternatives to Laboratory Animals, 44(4), pp. 361–381.
Johnson, E.A., D.S. Sharp and D.B. Miller (2000). Restraint as a Stressor in Mice:
Against the Dopaminergic Neurotoxicity of d-MDMA, Low Body Weight Mitigates
Restraint-induced Hypothermia and Consequent Neuroprotection. Brain Research,
875(1), pp. 107–118.
Johnson, J. and A. Smajdor (2019). Human wrongs in animal research—A focus on
moral injury and reification. In: K. Herrmann and K. Jayne, eds., Animal Experimentation: Working Towards a Paradigm Change, Vol. 22. Leiden: Brill.
Jones, J.M. (2017). Americans Hold Record Liberal Views on Most Moral Issues. Gallup
Poll Social Series. [online] Available at: http://www.gallup.com/poll/210542/ameri
cans-hold-record-liberal-views-moral-issues.aspx?g_source=2017+poll+animals&g
_medium=search&g_campaign=tiles [Accessed 10 June 2017].
Justice, M.J. and P. Dhillon (2016). Using the Mouse to Model Human Disease: Increasing Validity and Reproducibility. Disease Model Mechanisms, 9(2), pp. 101–103.
Kaplan, R.M. and V.L. Irvin (2015). Likelihood of Null Effects of Large NHLBI Clinical
Trials Has Increased Over Time. PLoS One, 10(8), p. e0132382. [online] Available at:
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0132382 [Accessed
10 June 2017].
Karp, C.L. (2012). Unstressing Intemperate Models: How Cold Stress Undermines
Mouse Modeling. Journal of Experimental Medicine, 209(6), pp. 1069–1074.
Keen, J. (2019). Wasted money in US biomedical and agricultural animal research. In: K.
Herrmann and K. Jayne, eds., Animal Experimentation: Working Towards a Paradigm
Change, Vol. 22. Leiden: Brill.
Kempermann, G., H.G. Kuhn and F.H. Gage (1997). More Hippocampal Neurons in
Adult Mice Living in an Enriched Environment. Nature, 386(6624), p. 493.

Refinement on the Way Towards Replacement

51

Kerr, N.L. (1998). HARKing: Hypothesizing After the Results Are Known. Personality
and Social Psychology Review, 2(3), pp. 196–217.
Kilkenny, C., W.J. Browne, I.C. Cuthill, M. Emerson and D.G. Altman (2010). Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting
Animal Research. PLoS Biology, 8(6), p. e1000412. [online] Available at: http://
journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1000412 [Accessed 14
May 2017].
Klein, H. and K. Bayne (2007). Establishing a Culture of Care, Conscience, and Responsibility: Addressing the Improvement of Scientific Discovery and Animal Welfare
Through Science-based Performance Standards. ILAR Journal, 48(1), pp. 3–11.
Knight, A. (2008). 127 Million Non-Human Vertebrates Used Worldwide for Scientific
Purposes in 2005. Alternatives to Laboratory Animals, 36(5), pp. 494–496.
Knight, A. (2019). Critically evaluating animal research. In: K. Herrmann and K. Jayne,
eds., Animal Experimentation: Working Towards a Paradigm Change, Vol. 22. Leiden:
Brill pp. 321–340.
Kola, I. and J. Landis (2004). Can the Pharmaceutical Industry Reduce Attrition Rates?
Nature Reviews Drug Discovery, 3(8), p. 711–715.
Kramer, L.A. and R. Greek (2018). Human Stakeholders and the Use of Animals in Drug
Development. Business and Society Review, 123(1), pp. 3–58.
Krech, D., M.R. Rosenzweig and E.L. Bennett (1960). Effects of Environmental Complexity and Training on Brain Chemistry. Journal of Comparative and Physiological
Psychology, 53, pp. 509–514.
Lahvis, G.P. (2017). Unbridle Biomedical Research From the Laboratory Cage. Elife, 6.
[online] Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503508/
[Accessed 4 July 2017].
Lancaster, M.A. and J.A. Knoblich (2014). Generation of Cerebral Organoids From
Human Pluripotent Stem Cells. Nature Protocols, 9(10), pp. 2329–2340.
Landis, S.C., S.G. Amara, K. Asadullah, C.P. Austin, R. Blumenstein, E.W. Bradley,
R.G. Crystal, R.B. Darnell, R.J. Ferrante, H. Fillit and R. Finkelstein (2012). A Call for
Transparent Reporting To Optimize The Predictive Value of Preclinical Research.
Nature, 490(7419), pp. 187–191.
Landrigan, P.J., R. Fuller, N.J. Acosta, O. Adeyi, R. Arnold, A.B. Baldé, R. Bertollini,
S. Bose-O, J.I. Boufford, P.N. Breysse and T. Chiles (2017). The Lancet Commission on
Pollution and Health. The Lancet, pp. 462–512.
Langley, G., I. Adcock, F. Busquet, K. Crofton, E. Csernok, C. Giese, T. Heinonen, K. Herrmann, M. Hofmann-Apitius, B. Landesmann, L. Marshall, E. McIvor, A. Muotri, F. Noor,
K. Schutte, T. Seidle, A. van de Stolpe, H. Van Esch, C. Willett and G. Woszczek (2017).
Towards a 21st Century Roadmap for Biomedical Research and Drug Discovery: Consensus Report and Recommendations. Drug Discovery Today, 22(2), pp. 327–339.
Langley, G., C.P. Austin, A.K. Balapure, L.S. Birnbaum, J.R. Bucher, J. Fentem, S.C. Fitzpatrick, J.R. Fowle iii, R.J. Kavlock, H. Kitano and B.A. Lidbury (2015). Lessons from

52

Herrmann

Toxicology: Developing a 21st Century Paradigm for Medical Research. Environmental Health Perspectives, 123(11), p. A268–A272.
Leary, S., W. Underwood, R. Anthony, S. Cartner, D. Corey, T. Grandin, C. Greenacre,
S. Gwaltney-Brant, M.A. McCrakin, R. Meyer and D. Miller (2013). AVMA Guidelines
for the Euthanasia of Animals, 2013 ed. [online] Available at: https://www.avma.org/
KB/Policies/Documents/euthanasia.pdf [Accessed 4 July 2017].
Lees, J.S., E.S. Sena, K.J. Egan, A. Antonic, S.A. Koblar, D.W. Howells and M.R. Macleod
(2012). Stem Cell-based Therapy for Experimental Stroke: A Systematic Review and
Meta-analysis. International Journal of Stroke, 7(7), pp. 582–588.
Leist, M. and T. Hartung (2013). Inflammatory Findings On Species Extrapolations:
Humans Are Definitely No 70 kg Mice. Archives of Toxicology, 87(4), pp. 563–567.
Lewis, M.H., M.F. Presti, J.B. Lewis and L.A. Turner (2006). The neurobiology of stereotypy i. Environmental complexity. In: G.J. Mason and J. Rushen, eds., Stereotypic
Animal Behaviour: Fundamentals and Applications to Welfare, 2nd ed. Oxfordshire:
CAB International, pp. 190–226.
Li, G., Y. Gan, Y. Fan, Y. Wu, H. Lin, Y. Song, X. Cai, X. Yu, W. Pan, M. Yao, J. Gu and
H. Tu (2015). Enriched Environment Inhibits Mouse Pancreatic Cancer Growth and
Down-regulates the Expression of Mitochondria-related Genes in Cancer Cells. Scientific Reports, 5, p. 7856. [online] Avaiable at: https://www.ncbi.nlm.nih.gov/pmc/
articles/PMC4297951/ [Accessed 1 July 2017].
Lilley, E., R. Armstrong, N. Clark, P. Gray, P. Hawkins, K. Mason, N. López-Salesansky,
A. Stark, S. Jackson, C. Thiemermann and M. Nandi (2015). Refinement of Animal
Models of Sepsis and Septic Shock. Shock, 43(4), pp. 304–316.
Lidster, K., J.G. Jefferys, I. Blümcke, V. Crunelli, P.A. Flecknell, B.G. Frenguelli, W.P. Gray,
R. Kaminski, A. Pitkänen, I. Ragan and M. Shah (2016). Opportunities for improving
animal welfare in rodent models of epilepsy and seizures. Journal of Neuroscience
Methods, 260, pp. 2–25.
Low, P. (2012). Cambridge Declaration on Consciousness. [online] Avaiable at: http://
fcmconference.org/img/CambridgeDeclarationOnConsciousness.pdf [Accessed 1
July 2017].
Lush Prize (n.d.). About the Lush Prize. [online] Available at: http://lushprize.org/
awards/ [Accessed 11 July 2018].
Macleod, M.R. (2011). Why Animal Research Needs To Improve: Many of The Studies
That Use Animals To Model Human Diseases Are Too Small and Too Prone To Bias
To Be Trusted. Nature, 477(7366), pp. 511–512.
Macleod, M.R., T. O’Collins, D.W. Howells and G.A. Donnan (2004). Pooling of Animal
Experimental Data Reveals Influence Of Study Design and Publication Bias. Stroke,
35(5), pp. 1203–1208.
Macleod, M.R., A. Lawson McLean, A. Kyriakopoulou, S. Serghiou, A. de Wilde, N. Sherratt, T. Hirst, R. Hemblade, Z. Bahor, C. Nunes-Fonseca, A. Potluru, A. Thomson,

Refinement on the Way Towards Replacement

53

J. Baginskitae, K. Egan, H. Vesterinen, G. Currie, L. Churilov, D. Howells and E. Sena
(2015). Risk of Bias in Reports of In Vivo Research: A Focus for Improvement. PLoS
Biology, 13(10), p. e1002273. [online] Available at: https://core.ac.uk/download/
pdf/45473665.pdf [Accessed 11 July 2017].
Macleod, M.R., H.B. van der Worp, E.S. Sena, D.W. Howells, U. Dirnagl and G.A. Donnan
(2008). Evidence for the Efficacy of NXY-059 in Experimental Focal Cerebral Ischaemia Is Confounded by Study Quality. Stroke, 39(10), pp. 2824–2829.
Mahoney, C.J. (1992). Some Thoughts on Psychological Enrichment. Lab Animal, 21(5),
pp. 27–37.
Mak, I.W., N. Evaniew and M. Ghert (2014). Lost in Translation: Animal Models and
Clinical Trials in Cancer Treatment. American Journal of Translational Research,
6(2), pp. 114–118.
Makowska, I.J. and D.M. Weary (2016a). Differences in Anticipatory Behaviour Between
Rats (Rattus Norvegicus) Housed In Standard Versus Semi-naturalistic Laboratory Environments. PLoS One, 11(1), p. e0147595. [online] Available at: https://doi
.org/10.1371/journal.pone.0147595 [Accessed 8 July 2017].
Makowska, I.J. and D.M. Weary (2016b). The Importance of Burrowing, Climbing, and
Standing Upright for Laboratory Rats. Royal Society Open Science, 3(6), p. 160136.
[online] Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929907/
[Accessed 8 July 2017].
Marks, J. (2012). Accept No Substitutes: The Ethics of Alternatives. Hastings Center
Report, 42(s1).
Martin, B., S. Ji, S. Maudsley and M.P. Mattson (2010). “Control” Laboratory Rodents
Are Metabolically Morbid: Why It Matters. Proceedings of the National Academy of
Sciences, 107(14), pp. 6127–6133.
Martire, V.L., A. Silvani, S. Bastianini, C. Berteotti and G. Zoccoli (2012). Effects of
Ambient Temperature on Sleep and Cardiovascular Regulation in Mice: The
Role of Hypocretin/Orexin Neurons. PLoS One, 7(10), p. e47032. [online] Available at: https://doi.org/10.1371/journal.pone.0047032 [Accessed on 23 February
2017].
Mason, G.J. (2006). Stereotypic Behaviour in Captive Animals: Fundamentals and
Implications for Welfare and Beyond. In: G. Mason and J. Rushen, eds., Stereotypic
Animal Behaviour: Fundamentals and Applications to Welfare, 2nd ed. Oxfordshire:
CAB International, pp. 325–356.
Maurin, J. (2012). Blutige Bisswunden, hungernde Mäuse. TAZ. [online] Available at:
http://www.taz.de/!5095484/ [Accessed on 23 February 2017].
McManus, R. (2013). Ex-Director Zerhouni Surveys Value of NIH Research. NIH Record, LXV(13). [online] Available at: https://nihrecord.nih.gov/newsletters/2013/06
_21_2013/story1.htm [Accessed on 23 February 2017].
McNutt, M., (2014). Journals Unite for Reproducibility. Science, 346(6210), p. 679.

54

Herrmann

Meagher, R.K. and G.J. Mason (2012). Environmental Enrichment Reduces Signs of
Boredom in Caged Mink. PLoS One, 7(11), p. e49180. [online] Available at: https://
doi.org/10.1371/journal.pone.0049180 [Accessed on 23 February 2017].
Meijer, M.K., B.M. Spruijt, L.F.M. Van Zutphen and V. Baumans (2006). Effect of
Restraint and Injection Methods on Heart Rate and Body Temperature in Mice.
Laboratory animals, 40(4), pp. 382–391.
Mergenthaler, P. and A. Meisel (2012). Do Stroke Models Model Stroke?. Disease Models
& Mechanisms, 5(6), pp. 718–725.
Messmer, M.N., K.M. Kokolus, J.W.L. Eng, S.I. Abrams and E.A. Repasky (2014). Mild
Cold-stress Depresses Immune Responses: Implications for Cancer Models Involving Laboratory Mice. Bioessays, 36(9), pp. 884–891.
Mestas, J. and C. Hughes (2004). Of Mice and Not Men: Differences Between Mouse
and Human Immunology. The Journal of Immunology, 172(5), pp. 2731–2738.
Moher, D., A. Liberati, J. Tetzlaff, D.G. Altman, The PRISMA Group (2009). Preferred
Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Medicine, 6(7), p. e1000097. [online] Available at: https://doi.org/10.1371/
journal.pmed.1000097 [Accessed 12 January 2017].
Morton, D. (2000). A Systematic Approach for Establishing Humane Endpoints. ILAR
Journal, 41(2), pp. 80–86.
Mullane, K. and M. Williams (2014). Animal Models of Asthma: Reprise or Reboot?.
Biochemical Pharmacology, 87(1), pp. 131–139.
National Animal Ethics Advisory Committee (2002). A Culture of Care: A Guide for People Working With Animals in Research, Testing and Teaching. Wellington, New Zealand. [online] Available at: https://anzccart.org.nz/app/uploads/2017/03/culture
-of-care.pdf [Accessed 10 June 2017].
National Research Council (2007). Toxicity Testing in the 21st Century: A Vision and a
Strategy. Washington, D.C.: National Academies Press.
National Toxicology Program (2004). A National Toxicology Program to the 21st Centruy. A Roadmap for the Future. [online] Available at: https://ntp.niehs.nih.gov/ntp/
about_ntp/ntpvision/ntproadmap_508.pdf [Accessed 11 January 2017].
NCad (n.d.). NCad opinion Transition to non-animal research. [online] Available at:
https://www.ncadierproevenbeleid.nl/documenten/rapport/2016/12/15/ncad-opin
ion-transition-to-non-animal-research [Accessed 11 July 2017].
NCATS (National Center for Advancing Translational Sciences) (2017). Tissue Chips for
Disease Modeling and Efficacy Testing. [online] Available at: https://ncats.nih.gov/
tissuechip/projects/modeling [Accessed 14 July 2017].
NAVS (2018). Fund Smarter Science. [online] Available at: https://www.navs.org/what
-we-do/fund-smarter-science/#.W1UAPi3Myu5 [Accessed 10 July 2018].
NC3Rs (n.d. a). Funding Scheme Priority Areas. [online] Available at: https://www
.nc3rs.org.uk/funding-scheme-priority-areas#historic [Accessed 16 July 2018].

Refinement on the Way Towards Replacement

55

NC3Rs (n.d. b). Experimental Design. [online] Available at: https://nc3rs.org.uk/exper
imental-design [Accessed 14 July 2017].
NC3Rs (n.d. c). Research Hubs. [online] Available at: https://nc3rs.org.uk/resource
-hubs [Accessed 14 July 2017].
NC3Rs (n.d. d). Our funding. [online] Available at: https://www.nc3rs.org.uk/about-us/
funders [Accessed 16 July 2018].
Nerem, R.M., M.J. Levensque and J.F. Cornhill (1980). Social Environment as a Factor of
Diet Induced Atherosclerosis. Science, 208, pp. 1475–1476.
NIH (2019). Budget. [online] Available at: https://www.nih.gov/about-nih/what-we
-do/budget [Accessed 14 February 2019].
Nithianantharajah, J. and A. Hannan (2006). Enriched Environments, Experience-
dependent Plasticity and Disorders of the Nervous System. Nature Reviews Neuroscience, 7(9), pp. 697–709.
NHMRC (National Health and Medical Research Council) (2013). Australian code
for the care and use of animals for scientific purposes. 8th ed. [online] Available
at: https://www.nhmrc.gov.au/guidelines-publications/ea28 [Accessed 11 July 2017].
Noor, F. (2019). The changing paradigm in preclinical toxicology: in vitro and in silico
methods in liver toxicity evaluations. In: K. Herrmann and K. Jayne, eds., Animal
Experimentation: Working Towards a Paradigm Change, Vol. 22. Leiden: Brill.
Norecopa (2016a). Culture of care. [online] Available at: https://norecopa.no/moreresources/culture-of-care [Accessed 11 August 2018].
Norecopa (2016b). Design and reporting of animal experiments. [online] Available
at: https://norecopa.no/more-resources/experimental-design-and-reporting [Accessed 12 August 2018].
Norecopa (2017). Systematic Review Centre for Laboratory Animal Experimentation
(SYRCLE). [online] Available at: https://norecopa.no/3r-guide/systematic-review
-centre-for-laboratory-animal-experimentation-syrcle [Accessed 12 August 2018].
O’Collins, V.E., M.R. Macleod, G.A. Donnan, L.L. Horky, B.H. van der Worp and
D.W. Howells (2006). 1,026 Experimental Treatments in Acute Stroke. Annals of Neurology, 59(3), pp. 467–477.
Olson, H., G. Betton, D. Robinson, K. Thomas, A. Monro, G. Kolaja, P. Lilly, J. Sanders,
G. Sipes, W. Bracken, M. Dorato, K. Van Deun, P. Smith, B. Berger and A. Heller
(2000). Concordance of the Toxicity of Pharmaceuticals in Humans and in Animals.
Regulatory Toxicology and Pharmacology, 32(1), pp. 56–67. [online] Available at:
https://www.gwern.net/docs/statistics/meta-analysis/2000-olson.pdf [Accessed 12
August 2017].
Olsson, I.A.S., C.M. Nevison, E.G. Patterson-Kane, C.M. Sherwin, H.A. van de Weerd
and H. Würbel (2003). Understanding Behaviour: The Relevance of Ethological
Approaches in Laboratory Animal Science. Applied Animal Behaviour Science, 81(3),
pp. 245–264.

56

Herrmann

Ormandy, E.H., C.A. Schuppli, and D.M. Weary (2009). Worldwide Trends in the Use
of Animals in Research: The Contribution of Genetically-modified Animal Models.
Alternatives to Laboratory Animals, 37, pp. 63–68.
Osborne, N., Avey, M.T., Anestidou, L., Ritskes‐Hoitinga, M. and Griffin, G. (2018). Improving animal research reporting standards: HARRP, the first step of a unified
approach by ICLAS to improve animal research reporting standards worldwide.
EMBO Reports , 19(5), p. e46069. [online] Available at: http://embor.embopress.org/
content/19/5/e46069 [Accessed 19 April 2018].
Pawlowski, J., D. Feinstein, M.L. Crandall and S. Gala (2019). Modernizing biomedical
training: replacing live animal laboratories with human simulation. In: K. Herrmann
and K. Jayne, eds., Animal Experimentation: Working Towards a Paradigm Change,
Vol. 22. Leiden: Brill, pp. 551–66.
Payne, K.J. and G.M. Crooks (2007). Immune-cell Lineage Commitment: Translation
From Mice to Humans. Immunity, 26(6), pp. 674–677.
Percie du Sert, N., A. Alfieri, S.M. Allan, H.V. Carswell, G.A. Deuchar, T.D. Farr, P. Flecknell, L. Gallagher, C.L. Gibson, M.J. Haley and M.R. Macleod (2017). The IMPROVE
Guidelines (Ischaemia Models: Procedural Refinements Of in Vivo Experiments).
Journal of Cerebral Blood Flow & Metabolism, p. 0271678X17709185. [online] Available at: http://journals.sagepub.com/doi/pdf/10.1177/0271678X17709185 [Accessed
18 August 2017].
Perel, P., I. Roberts, E. Sena, P. Wheble, C. Briscoe, P. Sandercock, M. Macleod, L.E. Mignini, P. Jayaram and K.S. Khan (2007). Comparison of Treatment Effects Between
Animal Experiments and Clinical Trials: Systematic Review. British Medical Journal,
334, pp. 197–206. [online] Available at: https://www.bmj.com/content/334/7586/197
[Accessed 12 July 2017].
PETA International Science Consortium (PISC) (n.d. a). Awards of VITROCELL In
Vitro Inhalation Exposure Systems. [online] Available at: https://www.piscltd.org.
uk/vitrocell-prize/ [Accessed 10 August 2017].
PETA International Science Consortium (PISC) (n.d. b). Funding to Advance the Development and Use of Non-Animal Methods. [online] Available at: https://www.piscltd
.org.uk/funding/ [Accessed 10 August 2018].
Pew Research Center (2015). Public and Scientists’ Views on Science and Society: Use
of Animals in Scientific Research. [online] Available at: http://www.pewinternet
.org/2015/01/29/public-and-scientists-views-on-science-and-society/pi_2015-01-29
_science-and-society-03-05/ [Accessed 10 July 2017].
Pew Research Center (2018). Americans are divided over the use of animals in scientific
research. [online] Available at: http://www.pewresearch.org/fact-tank/2018/08/16/
americans-are-divided-over-the-use-of-animals-in-scientific-research/. [Accessed
10 July 2017].
Pharmaceutical Research and Manufacturers of America (2015). Biopharmaceutical
research industry profile. Washington, DC: PhRMA. [online] Available at: http://

Refinement on the Way Towards Replacement

57

phrma-docs.phrma.org/sites/default/files/pdf/2015_phrma_profile.pdf [Accessed
10 July 2017].
Pharmaceutical Research and Manufacturers of America (2016). Biopharmaceutical
research industry profile. Washington, DC: PhRMA. [online] Available at: http://
phrma-docs.phrma.org/sites/default/files/pdf/biopharmaceutical-industry-profile
.pdf [Accessed 10 December 2017].
Pippin, J.J. (2012). Animal Research in Medical Sciences: Seeking a Convergence of Science, Medicine, and Animal Law. South Texas Law Review, 54, pp. 469–511.
Pippin, J.J., S.E. Cavanaugh and F. Pistollato (2019). Animal Research for Alzheimer Disease: Failures of Science and Ethics. In: K. Herrmann and K. Jayne, eds., Animal
Experimentation: Working Towards a Paradigm Change, Vol. 22. Leiden: Brill.
Pistollato, F., E.L. Ohayon, A. Lam, G.R. Langley, T.J. Novak, D. Pamies, G. Perry,
E. Trushina, R.S.B. Williams, A.E. Roher, T. Hartung, S. Harnard, N. Barnard, M.C. Morris, M. Lai, R. Merkley and P.C. Chandrasekera (2016). Alzheimer Disease research in
the 21st century: past and current failures, new perspectives and funding priorities.
Oncotarget, 7(26), pp. 38999–39016. [online] Available at: https://www.ncbi.nlm
.nih.gov/pmc/articles/PMC5129909/ [Accessed 10 July 2017].
Poole, T. (1997). Happy Animals Make Good Science. Laboratory Animals, 31(2),
pp. 116–124.
Pound, P. and M.B. Bracken (2014). Is Animal Research Sufficiently Evidence Based To
Be a Cornerstone of Biomedical Research?. British Medical Journal, 348, p. g3387.
Pound, P., S. Ebrahim, P. Sandercock, M.B. Bracken and I. Roberts (2004). Where Is
the Evidence That Animal Research Benefits Humans?. British Medical Journal,
328(7438), pp. 514–517.
Pound, P. and C.J. Nicol (2018). Retrospective Harm-benefit Analysis of Preclinical
Animal Research for Six Treatment Interventions. PLoS One, 13(3), p. e0193758.
[online] Available at: http://journals.plos.org/plosone/article?id=10.1371/journal
.pone.0193758 [Accessed 28 March 2018].
Pound, P. and Ritskes-Hoitinga, M. (2018). Is it possible to overcome issues of external validity in preclinical animal research? Why most animal models are bound
to fail. Journal of Translational Medicine, 16(1), p. 304. [online] Available at:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223056/ [Accessed 11 November
2018].
Preclinical Trials (n.d.). International Register for Preclincial Protocols. [online] Available at: https://www.preclinicaltrials.eu [Accessed 10 December 2017].
Prinz, F., T. Schlange and K. Asadullah (2011). Believe It or Not: How Much Can We Rely
on Published Data on Potential Drug Targets?. Nature Reviews Drug Discovery, 10(9),
pp. 712–712.
Ram, R. (2019). Extrapolation of animal research data to humans: an analysis of the
evidence. In: K. Herrmann and K. Jayne, eds., Animal Experimentation: Working
Towards a Paradigm Change, Vol. 22. Leiden: Brill.

58

Herrmann

Ramirez, T., S. Beken, M. Chlebus, G. Ellis, C. Griesinger, S. De Jonghe, I. Manou,
A. Mehling, K. Reisinger, L. Rossi, J. van der Laan, R. Weissenhorn and U. Sauer
(2015). Knowledge sharing to facilitate regulatory decision-making in regard to
alternatives to animal testing: Report of an EPAA workshop. Regulatory Toxicology
and Pharmacology, 73(1), pp. 210–226.
Redmond, C. (2019). When is an alternative not an alternative? Supporting progress
for absolute replacement of animals in science. In: K. Herrmann and K. Jayne, eds.,
Animal Experimentation: Working Towards a Paradigm Change, Vol. 22. Leiden: Brill.
Renner, M., M.A. Lancaster, S. Bian, H. Choi, T. Ku, A. Peer, K. Chung and J.A. Knoblich
(2017). Self-organized Developmental Patterning and Differentiation in Cerebral
Organoids. The EMBO Journal, p. e201694700. [online] Available at: http://emboj
.embopress.org/content/36/10/1316.long [Accessed 10 May 2017].
Reichlin, T.S., L. Vogt and H. Würbel (2016). The Researchers’ View of Scientific
Rigor—Survey on the Conduct and Reporting of In Vivo Research. PLoS One, 11(12),
p. e0165999. [online] Available at: https://doi.org/10.1371/journal.pone.0165999
[Accessed 10 January 2017].
Reinhardt, V. (2003). Compassion for Animals in the Laboratory: Impairment or
Refinement of Research Methodology?. Journal of Applied Animal Welfare Science,
6(2), pp. 123–130.
Richardson, C.A. and P.A. Flecknell (2005). Anaesthesia and Postoperative Analgesia
Following Experimental Surgery in Laboratory Rodents: Are We Making Progress?.
Alternatives to Laboratory Animals, 33, pp. 119–127.
Richter, S.H. (2017). Systematic Heterogenization for Better Reproducibility in Animal
Experimentation. Lab Animal, 46(9), pp. 343–349.
Richter, S.H., J.P. Garner and H. Würbel (2009). Environmental Standardization: Cure
or Cause of Poor Reproducibility in Animal Experiments?. Nature Methods, 6(4),
pp. 257–261.
Richter, S.H., J.P. Garner, C. Auer, J. Kunert and H. Würbel (2010). Systematic Variation
Improves Reproducibility of Animal Experiments. Nature Methods, 7(3), pp. 167–168.
Ritskes-Hoitinga, M. (2016). Systematic Reviews of Animal Studies Equal the Implementation of the 3Rs. In: 20th European Congress on Alternatives to Animal Testing,
17th Annual Congress of EUSAAT. Linz. [online] Availabe at: https://norecopa.no/
media/7597/systematic-reviews.pdf [Accessed 15 December 2017].
Ritskes-Hoitinga, M. and K. Wever (2018). Improving the Conduct, Reporting, and
Appraisal of Animal Research. Editorial. British Medical Journal, 360, p. j4935.
Rittirsch, D., L. Hoesel and P. Ward (2007). The Disconnect Between Animal Models of
Sepsis and Human Sepsis. Journal of Leukocyte Biology, 81(1), pp. 137–143.
Rosenzweig, M.R. (1966). Environmental Complexity, Cerebral Change, and Behavior.
American Psychologist, 21, pp. 321–332.
Rosenzweig, M.R. and E.L. Bennett (1969). Effects of Differential Environments on
Brain Weights and Enzyme Activities in Gerbils, Rats, and Mice. Developmental
Psychobiology, 2(2), pp. 87–95.

Refinement on the Way Towards Replacement

59

Rosenzweig, M.R., D. Krech, E.L. Bennett and J.F. Zolman (1962). Variation in Environmental Complexity and Brain Measures. Journal of Comparative and Physiological
Psychology, 55(6), p. 1092.
Røttingen, J.A., S. Regmi, M. Eide, A.J. Young, R.F. Viergever, C. Årdal, J. Guzman, D. Edwards, S.A. Matlin and R.F. Terry (2013). “Mapping of available health research and
development data: what’s there, what’s missing, and what role is there for a global
observatory?” The Lancet, 382 (9900), pp. 1286–1307.
Rovida, C., S. Asakura, M. Daneshian, H. Hofman-Huether, M. Leist, L. Meunier, D. Reif,
A Rossi, M. Schmutz, J. Valentin, J. Zurlo and T. Hartung (2015). Toxicity Testing in
the 21st Century Beyond Environmental Chemicals. Alternatives to Animal Experimentation, 32(3), pp. 171–181.
Russell, W.M.S. and R.L. Burch (1959). The Principles of Humane Experimental Technique. Potters Bar, Hertfordshire, England: Universities Federation for Animal Welfare. [online] Available at: http://altweb.jhsph.edu/pubs/books/humane_exp/het
-toc [Accessed 12 May 2017].
Salzberg, S.L., O. White, J. Peterson and J.A. Eisen (2001). Microbial Genes in the Human
Genome: Lateral Transfer or Gene Loss?. Science, 292 (5523), pp. 1903–1906.
Sandercock, P. and I. Roberts (2002b). Systematic Reviews of Animal Experiments. The
Lancet, 360, p. 586.
Scannell, J.W. and Bosley, J. (2016). When Quality Beats Quantity: Decision Theory, Drug
Discovery, and the Reproducibility Crisis. PLoS One, 11(2), p.e0147215. [online] Available at: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0147215
[Accessed 14 September 2017].
Scherer, R.W., Meerpohl, J.J., Pfeifer, N., Schmucker, C., Schwarzer, G. and von Elm, E.
(2018). Full publication of results initially presented in abstracts. Cochrane Database of Systematic Reviews 2018, Issue 11. Art. No.: MR000005. DOI: 10.1002/14651858.
MR000005.pub4.
Schmidt, D.A., M.R. Ellersieck, M.R. Cranfield and W.B. Karesh (2006). Cholesterol
Values in Free-ranging Gorillas (Gorilla Gorilla Gorilla and Gorilla Beringei) and
Bornean Orangutans (Pongo Pygmaeus). Journal of Zoo and Wildlife Medicine, 37(3),
pp. 292–300.
Schuppli, C., A. Walterhouse, V. Chew, N. Hammound, L. Kolody, B. Tan, J. Makowska, S.
Mcnamara, J. Sato-Reinhold, V. Wong and D. Weary (2017). A Better Life for Research
Animals by Fostering a Culture of Compassion Amongst Researchers. In: 10th World
Congress on Alternatives and Animal Use in the Life Sciences (WC10). Seattle: Alternatives to Animal Experimentation Proceedings, 6(1), p. 13. [online] Available at: http://
www.altex.ch/resources/WC10_entire_issue1.pdf [Accessed 12 September 2017].
Sena, E.S., H.B. van der Worp, P.M. Bath, D.W. Howells and M.R. Macleod (2010). Publication Bias in Reports of Animal Stroke Studies Leads To Major Overstatement
of Efficacy. PLoS Biology, 8(3), p. e1000344. [online] Available at: http://journals.
plos.org/plosbiology/article?id=10.1371/journal.pbio.1000344 [Accessed 12 August
2017].

60

Herrmann

Seok, J., H.S. Warren, A.G. Cuenca, M.N. Mindrinos, H.V. Baker, W. Xu, D.R. Richards,
G.P. McDonald-Smith, H. Gao, L. Hennessy and C.C. Finnerty (2013). Genomic
Responses in Mouse Models Poorly Mimic Human Inflammatory Diseases. Proceedings of the National Academy of Sciences, 110(9), pp. 3507–3512.
Serrat, M.A., D. King and C.O. Lovejoy (2008). Temperature Regulates Limb Length in
Homeotherms By Directly Modulating Cartilage Growth. Proceedings of the National Academy of Sciences, 105 (49), pp. 19348–19353.
Shay, T., V. Jojic, O. Zuk, K. Rothamel, D. Puyraimond-Zemmour, T. Feng, E. Wakamatsu,
C. Benoist, D. Koller and A. Regev (2013). Conservation and Divergence in the Transcriptional Programs of the Human and Mouse Immune Systems. Proceedings of the
National Academy of Sciences, 110(8), pp. 2946–2951.
Sherwin, C.M. (2004). The influences of Standard Laboratory Cages on Rodents and the
Validity of Research Data. Animal Welfare, 13(1), pp. 9–15.
Sherwin, C.M., E. Haug, N. Terkelsen and M. Vadgama (2004). Studies on the Motivation for Burrowing by Laboratory Mice. Applied Animal Behaviour Science, 88(3),
pp. 343–358.
Shuaib, A., K. Lees, P. Lyden, J. Grotta, A. Davalos, S. Davis, H. Diener, T. Ashwood, W.
Wasiewski and U. Emeribe (2007). NXY-059 for the Treatment of Acute Ischemic
Stroke. New England Journal of Medicine, 357(6), pp. 562–571.
Simmons, J.P., L.D. Nelson and U. Simonsohn (2011). False-positive Psychology: Undisclosed Flexibility in Data Collection and Analysis Allows Presenting Anything as
Significant. Psychological Science, 22 (11), pp. 1359–1366.
Sloff, M., R. de Vries, P. Geutjes, J. IntHout, M. Ritskes-Hoitinga, E. Oosterwijk and W.
Feitz (2014). Tissue Engineering in Animal Models for Urinary Diversion: A Systematic Review. PLoS one, 9(6), p. e98734. [online] Available at: http://journals.plos.org/
plosone/article?id=10.1371/journal.pone.0098734 [Accessed 30 July 2017].
Smith, A.J., R.E. Clutton, E. Lilley, K.E.A. Hansen and T. Brattelid (2017).
PREPARE: Guidelines for Planning Animal Research and Testing. Laboratory
Animals, pp. 135–141. [online] Available at: http://journals.sagepub.com/doi/pdf/
10.1177/0023677217724823 [Accessed 5 August 2017].
Smith, R. (2014). Medical Research—Still a Scandal. [Blog] British Medical Journal
Blog. Available at: https://blogs.bmj.com/bmj/2014/01/31/richard-smith-medical-re
search-still-a-scandal/ [Accessed 30 August 2017].
Sorge, R., L. Martin, K. Isbester, S. Sotocinal, S. Rosen, A. Tuttle, J. Wieskopf, E. Acland,
A. Dokova, B. Kadoura, P. Leger, J. Mapplebeck, M. McPhail, A. Delaney, G. Wigerblad, A. Schumann, T. Quinn, J. Frasnelli, C. Svensson, W. Sternberg and J. Mogil
(2014). Olfactory Exposure to Males, Including Men, Causes Stress and Related
Analgesia in Rodents. Nature Methods, 11(6), pp. 629–632.
Špinka, M. and F. Wemelsfelder (2011). Environmental challenge and animal agency. In:
M.C. Appleby, J.A. Mench, I.A.S. Olsson and B.O. Hughes, eds., Animal Welfare, 2nd
ed. Wallingford: CABI International, pp. 27–43.

Refinement on the Way Towards Replacement

61

Stokes, E., P. Flecknell and C. Richardson (2009). Reported Analgesic and Anaesthetic
Administration To Rodents Undergoing Experimental Surgical Procedures. Laboratory Animals, 43(2), pp. 149–154.
Systematic Review Center for Laboratory Animal Experimentation (SYRCLE) (n.d. a).
Systematic reviews of animal studies. [video] Available at: https://www.radboudumc
.nl/en/research/radboud-technology-centers/animal-research-facility/systematic
-review-center-for-laboratory-animal-experimentation [Accessed 12 July 2017].
SYRCLE (n.d. b). Tools and guidelines. [online] Available at: https://www.radboudumc
.nl/en/research/radboud-technology-centers/animal-research-facility/systematic
-review-center-for-laboratory-animal-experimentation [Accessed 12 July 2017].
SYRCLE (n.d. c). Protocols. Turner et al. (2017). The use of carbon dioxide as a method
for euthanasia of laboratory mice and rats – a systematic review. [online] Available at:
https://issuu.com/radboudumc/docs/the_use_of_carbon_dioxide_as_a_meth?e=28
355229/48248733 [Accessed 12 January 2018].
Taylor, K. and L. Rego (2016). EU statistics on Animal Experiments for 2014. Alternatives
to Animal Experimentation Proceedings, 33(4), pp. 465–468.
Taylor, K., N. Gordon, G. Langley and W. Higgins (2008). Estimates for Worldwide Laboratory Animal Use in 2005. Alternatives to Laboratory Animals, 36(3), pp. 327–342.
Tsai, P.P., U. Pachowsky, H.D. Stelzer and H. Hackbarth (2002). Impact of
Environmental Enrichment in Mice. 1: Effect of Housing Conditions on Body
Weight, Organ Weights and Haematology in Different Strains. Laboratory Animals,
36(4), pp. 411–419.
Tsai, P.P., H.D. Stelzer, H.J. Hedrich and H. Hackbarth (2003). Are the Effects of Different Enrichment Designs on the Physiology and Behaviour of DBA/2 Mice Consistent?. Laboratory Animals, 37(4), pp. 314–327.
Tsai, P.P., H.D. Stelzer, A. Schraepler and H. Hackbarth (2006). Importance and Effects
of Enrichment on Physiology, Behaviour and Breeding Performance in Mice. Alternatives to Animal Experimentation, 23, pp. 96–98.
Tsilidis, K., O. Panagiotou, E. Sena, E. Aretouli, E. Evangelou, D. Howells, R. Salman, M.
Macleod and J.P.A. Ioannidis (2013). Evaluation of Excess Significance Bias in Animal Studies of Neurological Diseases. PLoS Biology, 11(7), p. e1001609. [online] Available at: http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1001609
[Accessed 12 January 2018].
Tsukamoto, T. (2016) Animal Disease Models for Drug Screening: The Elephant in the
Room? Drug Discovery Today, 21, pp. 529–530.
Turner, J.G., J.L. Parrish, L.F. Hughes, L.A. Toth and D.M. Caspary (2005). Hearing in
Laboratory Animals: Strain Differences and Nonauditory Effects of Noise. Comparative Medicine, 55(1), pp. 12–23.
UC San Diego (2018). Biomedical Research using Non Animal Models. [online] Available
at: https://extension.ucsd.edu/courses-and-programs/biomedical-research-using
-non-animal-models [Accessed 12 July 2018].

62

Herrmann

Uhlig, C., H. Krause, T. Koch, M.G. de Abreu and P.M. Spieth (2015). Anesthesia and
Monitoring in Small Laboratory Mammals Used in Anesthesiology, Respiratory and
Critical Care Research: A Systematic Review on the Current Reporting in top-10
Impact Factor Ranked Journals. PLoS One, 10(8), p. e0134205. [online] Available at:
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0134205 [Accessed
18 July 2017].
van de Weerd, H.A., Aarsen, E.L., Mulder, A., Kruitwagen, C.L., Hendriksen, C.F. and
Baumans, V. (2002). Effects of environmental enrichment for mice: variation in experimental results. Journal of Applied Animal Welfare Science, 5(2), pp. 87–109.
van der Poll, T. (2012). Experimental Human Sepsis Models. Drug Discovery Today: Disease Models, 9(1), pp. e3–e9.
van der Worp, H.B., D.W. Howells, E.S. Sena, M.J. Porritt, S. Rewell, V. O and M.R. Macleod (2010). Can Animal Models of Disease Reliably Inform Human Studies? PLoS
Medicine, 7, pp. e1000245. [online] Available at: http://journals.plos.org/plosmedi
cine/article?id=10.1371/journal.pmed.1000245 [Accessed 15 August 2017].
van Luijk, J. (2016). Improving Animal Research Using a Science Driven Approach:
Sytematic Reviews of Animal Studies. In: 20th European Congress on Alternatives to
Animal Testing, 17th Annual Congress of EUSAAT. Linz. [online] Availabe at: https://
norecopa.no/media/7599/systematic-reviews-judith-van-luijk.pdf [Accessed 15
December 2017].
van Luijk, J., B. Bakker, M.M. Rovers, M. Ritskes-Hoitinga, R.B. de Vries and M. Leenaars (2014). Systematic Reviews of Animal Studies: Missing Link in Translational
Research?. PLoS One, 9(3), p. e89981. [online] Available at: http://journals.plos.org/
plosone/article?id=10.1371/journal.pone.0089981 [Accessed 15 August 2017].
van Luijk, J., Y. Cuijpers, L. van der Vaart, T.C. de Roo, M. Leenaars and M. Ritskes-
Hoitinga (2013). Assessing the Application of the 3Rs: A Survey Among Animal Welfare Officers in the Netherlands. Laboratory Animals, 47(3), pp. 210–219.
van Luijk, J., M. Leenaars, A.M. van Dongen, L. van der Vaart and M. Ritskes-Hoitinga
(2012). Outcomes of a Dutch Workshop on Improvements for the 3Rs in Daily Practice.
Alternatives to Animal Experimentation, 29(4), p. 440–443. [online] Available at: https://
www.altex.org/index.php/altex/article/view/439/447 [Accessed 15 August 2017].
van Praag, H., G. Kempermann and F.H. Gage (2000). Neural Consequences of Environmental Enrichment. Nature Reviews Neuroscience, 1(3), pp. 191–198.
vfa (Die forschenden Pharmaunternehmen) (2017). Tierschutz. Preise des Landes Berlin
für tierfreie Forschung zu Grippeviren und Schlaganfall verliehen. [online] Available at:
https://www.vfa.de/de/arzneimittel-forschung/forschungsstandort-deutschland/
preise-des-landes-berlin-fuer-tierfreie-forschung-zu-grippeviren-und-schlaganfall
-verliehen.html [Accessed 12 October 2017].
Voelkl, B., Vogt, L., Sena, E.S. and Würbel, H. (2018). Reproducibility of preclinical
animal research improves with heterogeneity of study samples. PLoS Biology, 16(2),
p. e2003693.

Refinement on the Way Towards Replacement

63

Vogt, L., T.S. Reichlin, C. Nathues and H. Würbel (2016). Authorization of Animal Experiments Is Based on Confidence Rather Than Evidence of Scientific Rigor. PLoS
Biology, 14 (12), p. e2000598. [online] Available at: http://journals.plos.org/plosbiol
ogy/article?id=10.1371/journal.pbio.2000598 [Accessed 12 July 2017].
von Aulock, S. (2017). The 3Rs in Action, Session viii-3: Establishing a Culture of Care
Through Assessment, Transparency, and Communication. In: 10th World Congress
on Alternatives and Animal Use in the Life Sciences (WC10). Seattle: Alternatives
to Animal Experimentation Proceedings, 6(1), p. 213. [online] Available at: http://
www.altex.ch/resources/WC10_entire_issue1.pdf [Accessed 22 August 2017].
Waiblinger, E. and B. König (2004). Refinement of Gerbil Housing and Husbandry in
the Laboratory. Alternatives to Laboratory Animals, 32 (1A), pp. 163–169.
Watts, N., M. Amann, S. Ayeb-Karlsson, K. Belesova, T. Bouley, M. Boykoff, P. Byass,
W. Cai, D. Campbell-Lendrum, J. Chambers and P.M. Cox (2017). The Lancet Countdown on Health and Climate Change: From 25 Years of Inaction to a Global Transformation for Public Health. The Lancet, 391 (10120), pp. 581–630.
Weed, J. and J. Raber (2005). Balancing Animal Research With Animal Well-being:
Establishment of Goals and Harmonization of Approaches. ILAR Journal, 46(2),
pp. 118–128.
Wells, S. (2017). Pain Assessment and New Innovations. In: 10th World Congress on Alternatives and Animal Use in the Life Sciences (WC10). Seattle: Alternatives to Animal
Experimentation Proceedings, 6(1), p. 222. [online]Available at: http://www.altex
.ch/resources/WC10_entire_issue1.pdf [Accessed 22 August 2017].
Wever, K.E., F.J. Geessink, M.A. Brouwer, A. Tillema and M. Ritskes-Hoitinga (2017).
A systematic review of discomfort due to toe or ear clipping in laboratory rodents.
Laboratory Animals, 51(6), pp. 583–600.
Wiedenmayer, C. (1997). Causation of the Ontogenetic Development of Stereotypic
Digging in Gerbils. Animal Behaviour, 53(3), pp. 461–470.
Wolfensohn, S., P. Hawkins, E. Lilley, D. Anthony, C. Chambers, S. Lane, M. Lawton,
H. Voipio and G. Woodhall (2013a). Reducing Suffering in Experimental Autoimmune Encephalomyelitis (EAE). Journal of Pharmacological and Toxicological
Methods, 67(3), pp. 169–176.
Wolfensohn, S., P. Hawkins, E. Lilley, D. Anthony, C. Chambers, S. Lane, M. Lawton,
S. Robinson, H. Voipio and G. Woodhall (2013b). Reducing Suffering in Animal Models and Procedures Involving Seizures, Convulsions and Epilepsy. Journal of Pharmacological and Toxicological Methods, 67(1), pp. 9–15.
Wolfer, D., O. Litvin, S. Morf, R. Nitsch, H. Lipp and H. Würbel (2004). Laboratory Animal Welfare: Cage Enrichment and Mouse Behaviour. Nature, 432(7019), pp. 821–822.
Wolfle, T.L. (1987). Control of Stress Using Non-drug Approaches. Journal of the American Veterinary Medical Association, 191, pp. 1219–1221.
World Organisation for Animal Health (OIE) (2018). Terrestrial Animal Health Code, Ch.
7.8. Paris: World Organisation for Animal Health, first adopted in 2010; most recent

64

Herrmann

update adopted in 2013. [online] Available at: http://www.oie.int/index.php?id
=169&L=0&htmfile=chapitre_aw_research_education.htm [Accessed 12 May 2017].
Würbel, H. (2000). Behaviour and the Standardization Fallacy. Nature Genetics, 26,
p. 263.
Würbel, H. (2001). Ideal homes? Housing Effects on Rodent Brain and Behaviour.
Trends in Neuroscience. 24, pp. 207–211.
Würbel, H. (2007). Environmental Enrichment Does Not Disrupt Standardisation of
Animal Experiments. Alternatives to Animal Experimentation, 24, pp. 70–73.
Würbel, H. (2016). Tierversuch und Irrtum. In: M. Fehlmann, M. Michel and R. Niederhauser, eds. Tierisch! Das Tier und die Wissenschaft: Ein Streifzug durch die Disziplinen, Reihe Zürcher Hochschulforum, 55, pp. 97–106.
Würbel, H. (2017). More Than 3Rs: The Importance of Scientific Validity for Harm-benefit
Analysis of Animal Research. Nature Lab Animal, 46(4), pp. 164–166. [online] Available at: https://www.nature.com/articles/laban.1220.pdf [Accessed 12 June 2017].
Würbel, H. and J.P. Garner (2007). Refinement of Rodent Research Through Environ
mental Enrichment and Systematic Randomization. National Centre for the Replacement, Refinement, and Reduction of Animals in Research (NC3Rs). [online] Available at:
https://www.nc3rs.org.uk/sites/default/files/documents/Refinementenvironmen
talenrichmentandsystematicrandomization.pdf [Accessed 12 August 2017].
Würbel, H. and M. Stauffacher (1994). Standardhaltung für Labormäuse—Probleme
und Lösungsansätze. Tierlaboratorium, 17, pp. 109–118.
Würbel, H. and M. Stauffacher (1996). Prevention of Stereotypy in Laboratory
Mice: Effects on Stress Physiology and Behaviour. Physiology & Behavior, 59(6),
pp. 1163–1170.
Würbel, H., M. Stauffacher and D. Holst (1996). Stereotypies in Laboratory Mice—
Quantitative and Qualitative Description of the Ontogeny of ‘Wire-gnawing’and
‘Jumping’in Zur: ICR and Zur: ICR nu. Ethology, 102(3), pp. 371–385.
Zeeff, S.B., C. Kunne, G. Bouma, R.B. de Vries and A.A. Te Velde (2016). Actual usage and
Quality of Experimental Colitis Models in Preclinical Efficacy Testing: A Scoping
Review. Inflammatory Bowel Diseases, 22(6), pp. 1296–1305.
Zerhouni, E.A. (2014). Turning the Titanic. Science Translational Medicine, 6(221),
p. 221ed2.
Zurlo, J. (2012). No Animals Harmed: Toward a Paradigm Shift in Toxicity Testing. Hastings Center Report, 42(s1). [online] Available at: http://animalresearch.thehastings
center.org/report/no-animals-harmed-toward-a-paradigm-shift-in-toxicity-testing/
[Accessed 12 June 2017].
Zurlo, J., D. Rudacille and A.M. Goldberg (1996). The Three R’s: The Way Forward. Environmental Health Perspectives, 104(8), pp. 878–880.

